CA2538476A1 - Devices, systems, and methods for suturing tissue - Google Patents
Devices, systems, and methods for suturing tissue Download PDFInfo
- Publication number
- CA2538476A1 CA2538476A1 CA002538476A CA2538476A CA2538476A1 CA 2538476 A1 CA2538476 A1 CA 2538476A1 CA 002538476 A CA002538476 A CA 002538476A CA 2538476 A CA2538476 A CA 2538476A CA 2538476 A1 CA2538476 A1 CA 2538476A1
- Authority
- CA
- Canada
- Prior art keywords
- tissue
- tissue engaging
- engaging member
- suturing
- suturing device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B17/0644—Surgical staples, i.e. penetrating the tissue penetrating the tissue, deformable to closed position
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/068—Surgical staplers, e.g. containing multiple staples or clamps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/00234—Surgical instruments, devices or methods, e.g. tourniquets for minimally invasive surgery
- A61B2017/00238—Type of minimally invasive operation
- A61B2017/00243—Type of minimally invasive operation cardiac
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00579—Barbed implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00592—Elastic or resilient implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/00606—Implements H-shaped in cross-section, i.e. with occluders on both sides of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/0057—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect
- A61B2017/00575—Implements for plugging an opening in the wall of a hollow or tubular organ, e.g. for sealing a vessel puncture or closing a cardiac septal defect for closure at remote site, e.g. closing atrial septum defects
- A61B2017/0061—Implements located only on one side of the opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0409—Instruments for applying suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/04—Surgical instruments, devices or methods, e.g. tourniquets for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0419—H-fasteners
Abstract
The invention relates to devices, systems, and methods for percutaneously suturing biological material, such as a patient's tissues. In one embodiment, a suturing device includes first (140) and second (142) tissue engaging members connected to one another by a first interconnecting member (144). In another embodiment, systems and methods are provided for forming holes through two overlapping layers (60, 62) of tissue. Subsequent to forming holes through the two layers of tissue, the suturing device is positioned through the holes to join or bring into contact the two layers of overlapping tissue.
Description
DEVICES, SYSTEMS, AND METHODS FOR SUTURING TISSUE
Cross-Reference to Related Application [0001] This application incorporates by reference, and claims priority to and the benefit of, United States provisional application Serial No. 60/501,94, which was filed on September 11, 2003.
Technical Field [0002] The invention generally relates to devices, systems, and methods for percutaneously suturing tissue. More particularly, the invention relates to a suturing device that includes at least two tissue engaging members coimected to one another by an interconnecting member.
Bacl~~round io [0003] A septum is generally defined as a dividing musculax wall, membrane, or tissue between two or more bodily spaces. For example, the human heart is divided into four compartments or chambers. The left and right atria are located in the upper portion of the heart and the left and right ventricles are located in the lower portion of the heart. The left and right atria are separated from each other by the intraatrial septum, while the ventricles are separated by the 15 intraventricular septum.
[0004] Septal defects can take various forms. An exemplary septal defect is a patent foramen ovate. The patent foramen ovate is a persistent, one-way, usually flap-like opening or tunnel in the wall between the right atrium and the left atrium of the heart. More specifically, the patent foramen ovate is formed by two layers of partially overlapping, but unfused, cardiac tissue (i. e., 2o the septum primum and the septum secundum).
[0005] Under certain conditions, right atrial pressure exceeds left atrial pressure, creating the possibility for right to left shunting of blood through the patent foramen ovate. Blood clots may thereby enter the systemic circulation. This is particularly problematic for patients who are prone to forming venous thrombus, such as those with deep vein thrombosis or clotting abnormalities.
[0006] Improved devices, systems, and methods for suturing septal defects, such as, for example, ~ patent foramen ovale, are needed.
Summarv of the Invention [0007] The present invention relates to devices, systems, and methods for suturing together biological material, such as layers of tissue. In particular, in one embodiment, the present invention facilitates the percutaneous closure of a patent foramen ovale.
According to an 1o embodiment of the invention, the physician forms holes, for example, through the septum secundum and the septum primum in an area where the septa overlap. Subsequent to forming the holes, the physician positions the suturing device of the invention through the holes to bring into contact the two overlapping layers of tissue. Optionally, the physician also uses a tissue stabilization device to facilitate the procedure of closing the patent foramen ovale.
[0008] In general, in one aspect, the invention relates to a suturing system.
The suturing system includes a suturing device, which itself includes first and second tissue engaging members and a first interconnecting member. The first tissue engaging member includes a first end, a second end, and a first intermediate portion positioned between the first end and the second end, while the second tissue engaging member includes a third end, a fourth end, and a second intermediate portion positioned between the third end and the fourth end. The first interconnecting member includes a first fixed end connected to the first intermediate portion of the first tissue engaging member, and a second fixed end connected to the second tissue engaging member.
The suturing device is insertable into a patient in this connected configuration.
[0009] Various embodiments of this aspect of the invention include the following features. The second fixed end of the first interconnecting member may be connected to the second intermediate portion of the second tissue engaging member. The first and/or second tissue engaging members may be substantially cylindrical and they may have an atramnatic structure.
For example, one or more ends of the first and/or second tissue engaging members may be rounded. In another embodiment, the first interconnecting member is made, either entirely or in part, from a resilient material. In one such embodiment, the first interconnecting member is reciprocally moveable between an unstressed position and a deformed position.
In yet another embodiment, the first interconnecting member includes a stretchable material.
[0010] In still another embodiment, the tissue engaging members and/or the first interconnecting member include a material for stimulating tissue growth, such as, for example, collagen.
to Alternatively, the tissue engaging members and/or the first interconnecting member include a bioabsorbable material, such as, for example, a polylactic acid.
[0011] In one embodiment, the suturing device further includes a second interconnecting member connected to the first tissue engaging member and/or the second tissue engaging member. Moreover, the suturing device may further include a third tissue engaging member comiected to the second interconnecting member, or, alternatively, to the first fixed end or the second fixed end of the first intercorulecting member.
[0012] In a further embodiment, the suturing system also includes an elongate member. The elongate member includes a proximal end, a distal end, a wall extending from the proximal end to the distal end, and a cutting member positioned at the distal end. In one such embodiment, the 2o wall of the elongate member defines a lumen that extends from the proximal end to the distal end of the elongate member, and the wall also defines an opening at the distal end of the elongate member. Moreover, the suturing device and a delivery member, which may be releasably connected to the suturing device, may be disposed within the lumen of the elongate member.
Also, the elongate member may further include a retractable gate member positioned at the distal ' end of the elongate member. Alternatively, in another such embodiment, the first tissue engaging member includes a first lumen that extends from the first end to the second end of the first tissue engaging member, the second tissue engaging member includes a second lumen that extends from the third end to the fourth end of the second tissue engaging member, and the elongate member is disposed within the first lumen of the first tissue engaging member and also within the second lumen of the second tissue engaging member.
[0013] In another aspect, the invention provides another suturing device. The suturing device includes a first tissue engaging member, a second tissue engaging member, a first interconnecting member connecting the first tissue engaging member to the second tissue engaging member, and a first anchor connected to the first tissue engaging member.
to (0014] In one embodiment of this aspect of the invention, the suturing device fizrther includes a second anchor connected to the second tissue engaging member. One or both of the first anchor and the second anchor may be a spiral tissue anchor or a barbed tissue anchor.
[0015] In yet another aspect, the invention provides methods for suturing tissue. The methods include inserting one of the suturing devices described above into a heart of a patient and attaching the suturing device to one or more tissue surfaces in the heart of the patient.
[0016] In one embodiment of this aspect of the invention, the septum primum and the septum secundum are the tissue surfaces in the heart of the patient to which the suturing device is attached. In one such embodiment, the method for suturing tissue further includes positioning a tissue stabilization device in a patent foramen ovate.
[0017] In another embodiment, attaching the suturing device to the tissue surfaces in the heart of a patient includes extending the first tissue engaging member through a first hole in a first tissue layer and through a second hole in a second tissue layer, positioning the first tissue engaging member on a tissue surface of the second tissue layer, and positioning the second tissue engaging member on a tissue surface of the first tissue layer. Alternatively, in yet another embodiment, attaching the suturing device to the tissue surfaces in the heart of the patient includes extending the first tissue engaging member through a first hole in a first tissue layer, positioning the first tissue engaging member on a tissue surface of the first tissue layer, extending the second tissue engaging member through a second hole in a second tissue layer, and positioning the second tissue engaging member on a tissue surface of the second tissue layer.
[0018] The foregoing and other objects, aspects, features, and advantages of the invention will become more apparent from the following description and from the claims.
Brief Description of the Drawings [0019] In the drawings, like reference characters generally refer to the same parts throughout the different views. Also, the drawings axe not necessarily to scale, emphasis instead generally 1o being placed on illustrating the principles and concepts of the invention.
[0020] FIG. 1 is a cutaway view of a heart illustrating a patent foramen ovale.
[0021] FIG. 2 is a schematic fragmented view of a tissue suturing system according to an illustrative embodiment of the invention.
[0022] FIG. 3 is a schematic cross-sectional view of a distal end of an elongate member for a 15 tissue suturing system, with a gate member of the elongate member in an extended position, according to an illustrative embodiment of the invention.
[0023] FIG. 4 is a schematic cross-sectional view of the distal end of the illustrative elongate member of FIG. 3 with the gate member of the elongate member in a retracted position.
[0024] FIG. 5 is a schematic perspective view of a suturing device in a connected configuration 20 according to an illustrative embodiment of the invention.
[0025] FIG. 6 is a schematic fragmented view of a tissue suturing system according to another illustrative embodiment of the invention.
[0026] FIG. 7 is a schematic perspective view of a suturing device according to another illustrative embodiment of the invention.
Cross-Reference to Related Application [0001] This application incorporates by reference, and claims priority to and the benefit of, United States provisional application Serial No. 60/501,94, which was filed on September 11, 2003.
Technical Field [0002] The invention generally relates to devices, systems, and methods for percutaneously suturing tissue. More particularly, the invention relates to a suturing device that includes at least two tissue engaging members coimected to one another by an interconnecting member.
Bacl~~round io [0003] A septum is generally defined as a dividing musculax wall, membrane, or tissue between two or more bodily spaces. For example, the human heart is divided into four compartments or chambers. The left and right atria are located in the upper portion of the heart and the left and right ventricles are located in the lower portion of the heart. The left and right atria are separated from each other by the intraatrial septum, while the ventricles are separated by the 15 intraventricular septum.
[0004] Septal defects can take various forms. An exemplary septal defect is a patent foramen ovate. The patent foramen ovate is a persistent, one-way, usually flap-like opening or tunnel in the wall between the right atrium and the left atrium of the heart. More specifically, the patent foramen ovate is formed by two layers of partially overlapping, but unfused, cardiac tissue (i. e., 2o the septum primum and the septum secundum).
[0005] Under certain conditions, right atrial pressure exceeds left atrial pressure, creating the possibility for right to left shunting of blood through the patent foramen ovate. Blood clots may thereby enter the systemic circulation. This is particularly problematic for patients who are prone to forming venous thrombus, such as those with deep vein thrombosis or clotting abnormalities.
[0006] Improved devices, systems, and methods for suturing septal defects, such as, for example, ~ patent foramen ovale, are needed.
Summarv of the Invention [0007] The present invention relates to devices, systems, and methods for suturing together biological material, such as layers of tissue. In particular, in one embodiment, the present invention facilitates the percutaneous closure of a patent foramen ovale.
According to an 1o embodiment of the invention, the physician forms holes, for example, through the septum secundum and the septum primum in an area where the septa overlap. Subsequent to forming the holes, the physician positions the suturing device of the invention through the holes to bring into contact the two overlapping layers of tissue. Optionally, the physician also uses a tissue stabilization device to facilitate the procedure of closing the patent foramen ovale.
[0008] In general, in one aspect, the invention relates to a suturing system.
The suturing system includes a suturing device, which itself includes first and second tissue engaging members and a first interconnecting member. The first tissue engaging member includes a first end, a second end, and a first intermediate portion positioned between the first end and the second end, while the second tissue engaging member includes a third end, a fourth end, and a second intermediate portion positioned between the third end and the fourth end. The first interconnecting member includes a first fixed end connected to the first intermediate portion of the first tissue engaging member, and a second fixed end connected to the second tissue engaging member.
The suturing device is insertable into a patient in this connected configuration.
[0009] Various embodiments of this aspect of the invention include the following features. The second fixed end of the first interconnecting member may be connected to the second intermediate portion of the second tissue engaging member. The first and/or second tissue engaging members may be substantially cylindrical and they may have an atramnatic structure.
For example, one or more ends of the first and/or second tissue engaging members may be rounded. In another embodiment, the first interconnecting member is made, either entirely or in part, from a resilient material. In one such embodiment, the first interconnecting member is reciprocally moveable between an unstressed position and a deformed position.
In yet another embodiment, the first interconnecting member includes a stretchable material.
[0010] In still another embodiment, the tissue engaging members and/or the first interconnecting member include a material for stimulating tissue growth, such as, for example, collagen.
to Alternatively, the tissue engaging members and/or the first interconnecting member include a bioabsorbable material, such as, for example, a polylactic acid.
[0011] In one embodiment, the suturing device further includes a second interconnecting member connected to the first tissue engaging member and/or the second tissue engaging member. Moreover, the suturing device may further include a third tissue engaging member comiected to the second interconnecting member, or, alternatively, to the first fixed end or the second fixed end of the first intercorulecting member.
[0012] In a further embodiment, the suturing system also includes an elongate member. The elongate member includes a proximal end, a distal end, a wall extending from the proximal end to the distal end, and a cutting member positioned at the distal end. In one such embodiment, the 2o wall of the elongate member defines a lumen that extends from the proximal end to the distal end of the elongate member, and the wall also defines an opening at the distal end of the elongate member. Moreover, the suturing device and a delivery member, which may be releasably connected to the suturing device, may be disposed within the lumen of the elongate member.
Also, the elongate member may further include a retractable gate member positioned at the distal ' end of the elongate member. Alternatively, in another such embodiment, the first tissue engaging member includes a first lumen that extends from the first end to the second end of the first tissue engaging member, the second tissue engaging member includes a second lumen that extends from the third end to the fourth end of the second tissue engaging member, and the elongate member is disposed within the first lumen of the first tissue engaging member and also within the second lumen of the second tissue engaging member.
[0013] In another aspect, the invention provides another suturing device. The suturing device includes a first tissue engaging member, a second tissue engaging member, a first interconnecting member connecting the first tissue engaging member to the second tissue engaging member, and a first anchor connected to the first tissue engaging member.
to (0014] In one embodiment of this aspect of the invention, the suturing device fizrther includes a second anchor connected to the second tissue engaging member. One or both of the first anchor and the second anchor may be a spiral tissue anchor or a barbed tissue anchor.
[0015] In yet another aspect, the invention provides methods for suturing tissue. The methods include inserting one of the suturing devices described above into a heart of a patient and attaching the suturing device to one or more tissue surfaces in the heart of the patient.
[0016] In one embodiment of this aspect of the invention, the septum primum and the septum secundum are the tissue surfaces in the heart of the patient to which the suturing device is attached. In one such embodiment, the method for suturing tissue further includes positioning a tissue stabilization device in a patent foramen ovate.
[0017] In another embodiment, attaching the suturing device to the tissue surfaces in the heart of a patient includes extending the first tissue engaging member through a first hole in a first tissue layer and through a second hole in a second tissue layer, positioning the first tissue engaging member on a tissue surface of the second tissue layer, and positioning the second tissue engaging member on a tissue surface of the first tissue layer. Alternatively, in yet another embodiment, attaching the suturing device to the tissue surfaces in the heart of the patient includes extending the first tissue engaging member through a first hole in a first tissue layer, positioning the first tissue engaging member on a tissue surface of the first tissue layer, extending the second tissue engaging member through a second hole in a second tissue layer, and positioning the second tissue engaging member on a tissue surface of the second tissue layer.
[0018] The foregoing and other objects, aspects, features, and advantages of the invention will become more apparent from the following description and from the claims.
Brief Description of the Drawings [0019] In the drawings, like reference characters generally refer to the same parts throughout the different views. Also, the drawings axe not necessarily to scale, emphasis instead generally 1o being placed on illustrating the principles and concepts of the invention.
[0020] FIG. 1 is a cutaway view of a heart illustrating a patent foramen ovale.
[0021] FIG. 2 is a schematic fragmented view of a tissue suturing system according to an illustrative embodiment of the invention.
[0022] FIG. 3 is a schematic cross-sectional view of a distal end of an elongate member for a 15 tissue suturing system, with a gate member of the elongate member in an extended position, according to an illustrative embodiment of the invention.
[0023] FIG. 4 is a schematic cross-sectional view of the distal end of the illustrative elongate member of FIG. 3 with the gate member of the elongate member in a retracted position.
[0024] FIG. 5 is a schematic perspective view of a suturing device in a connected configuration 20 according to an illustrative embodiment of the invention.
[0025] FIG. 6 is a schematic fragmented view of a tissue suturing system according to another illustrative embodiment of the invention.
[0026] FIG. 7 is a schematic perspective view of a suturing device according to another illustrative embodiment of the invention.
[0027] FIG. 8 is a schematic side view of a suturing device according to another illustrative embodiment of the invention.
[0028] FIG. 9 is a schematic side view of a suturing device according to another illustrative .
embodiment of the invention.
[0029] FIG. 10 is a schematic side view of a suturing device according to another illustrative embodiment of the invention.
[0030] FIG. 11 is a schematic side view of a suturing device according to another illustrative embodiment of the invention.
[0031] FIGS. 12A-12D illustrate the stages in one embodiment of a method for suturing the l0 intraatrial septum in the heart of a patient in accordance with the invention.
[0032] FIG. 13 illustrates a suturing device implanted into the intraatrial septum in the heart of a patient in accordance with another embodiment of the invention.
[0033] FIG. 14 illustrates a suturing device implanted into the intraatrial septum in the heart of a patient in accordance with another embodiment of the invention.
Description [0034] The present invention relates to devices, systems, and methods for percutaneously suturing together biological material, such as layers of tissue. For example, in accordance with the invention, the septum primum and the septum secundum of a patent foramen ovate are sutured together.
2o [0035] Throughout the description, where devices are described as having, including, or comprising specific components, or where methods are described as having, including, or comprising specific method steps, it is contemplated that the devices of the present invention also consist essentially of, or consist of, the recited components, and that the methods of the present invention also consist essentially of, or consist of, the recited method steps.
[0036] In broad overview, a suturing device of the invention includes, in one embodiment, two tissue engaging members interconnected by an interconnecting member. In order to suture together two layers of tissue, the suturing device of the invention is, in one embodiment, placed through holes formed in the two layers of tissue. Each of the two tissue engaging members then engages one of the two layers of tissue. Optionally, a suturing system of the invention includes a cutting member for forming the holes in the layers of tissue.
[0037] FIG. 1 depicts a cutaway view of a heart 50, including an exemplary abnormal opening, a patent foramen ovale 52, that can be corrected by the devices, systems, and methods of the present invention. The view of the heart 50 depicted in FIG. 1 includes a septum 54 that divides a right atrium 56 from a left atrium 58. The septum 54 includes a septum primum 60 and a septum secundum 62. The patent foramen ovate 52 is located between the septum primum 60 and the septum secundum 62. The patent foramen ovate 52 provides an undesirable fluid communication between the right atrium 56 and the left atrium 58 and, under certain conditions, allows for the shunting of blood from the right atrium 56 to the left atrium 58. If the patent foramen ovate 52 is not closed or obstructed in some manner, a patient is placed at high risk for an embolic stroke.
[0038] FIG. 2 depicts a tissue suturing system 100 according to an illustrative embodiment of the invention. In one embodiment, the tissue suturing system 100 includes a sheath 102, an elongate member 104, a delivery member 106, a suturing device 108, an interface 110, a first controller 112, and a second controller 114.
[0039] In one embodiment, the sheath 102 includes a proximal end 116 (i. e., an end that is closest to a physician when the physician is operating the tissue suturing system 100) and an opposite, distal end 118. In one embodiment, the proximal end 116 of the sheath 102 is connected to the interface 110. In another embodiment, the sheath 102 defines a lumen 120 that extends from the proximal end 116 to the distal end 118 of the sheath 102, and an opening 122 _g_ located at the distal end 118 of the sheath 102. The opening 122 is in fluid communication with the lumen 120 of the sheath 102. In one embodiment, the sheath 102 is a transseptal sheath, such as, for example, item number RCF-10.0-38-80-J-RB Large Check-Flo ' Blue Introducer Set, which is manufactured by Cook Incorporated of Bloomington, Indiana.
[0040] With continued reference to FIG. 2, at least partially disposed within the lumen 120 of the sheath 102 is the elongate member 104. The elongate member 104 includes a proximal end 124, an opposite, distal end 126, and a wall 128 extending from the proximal end 124 to the distal end 126. In one embodiment, the wall 128 of the elongate member 104 defines a lumen 130 that extends from the proximal end 124 to the distal end 126 of the elongate member 104, to and an opening 132 at the distal end 126 of the elongate member 104. In another embodiment, the elongate member 104 includes, at its distal end 126, a cutting member 134 that is used, for example, to create one or more holes through a patient's tissues. The cutting member 134 may be, for example, a sharp point or protrusion formed at the distal end 126 of the elongate member 104 by, for example, trimming the distal end 126 of the elongate member 104 at an angle from a line 133 drawn perpendicular to the long axis of the elongate member 104.
[0041] The elongate member 104 according to the invention can achieve an extended position and a retracted position. Referring to FIG. 2, in the extended position of the elongate member 104, a distal portion 135 of the elongate member 104 is positioned distal to the distal end 118 of the sheath 102. In the retracted position of the elongate member 104, the entire elongate member 104 is positioned proximal to the distal end 118 of the sheath 102, i. e., within the lumen 120 of the sheath 102 (not shown). The sheath 102 may thus enclose the cutting member 134 of the elongate member 104 while the physician inserts the tissue suturing system 100 into the heart of a patient.
[0042] In one embodiment, the elongate member 104 is reciprocally moved between the extended and retracted positions by slideable movement of the elongate member 104 within the lumen 120 of the sheath 102 along the longitudinal axis of the sheath 102.
Alternatively, the elongate member 104 may be stationary and may be alternated between the extended position and the retracted position by proximally withdrawing the sheath 102 over the elongate member 104 to extend the elongate member 104, and by distally advancing the sheath 102 over the elongate member 104 to retract the elongate member 104.
[0043] Referring still to FIG. 2, in one embodiment, the delivery member 106 and the suturing device 108 axe iiutially disposed within the lmnen 130 of the elongate member 104. The exemplary delivery member 106 includes a proximal end 136 and an opposite, distal end 138.
The distal end 138 of the delivery member 106 may be positioned adjacent the suturing device l0 108 to engageably contact the suturing device 108. In one embodiment, the distal end 138 of the delivery member 106 is releasably connected to the suturing device 108. For example, the distal end 138 of the delivery member 106 may include a mechanical claw (not shown) for grasping and releasing the suturing device 108. Alternatively, in another embodiment, the suturing device 108 includes an eyelet (not shown). In one such embodiment, thread (not shown) is connected to the delivery member 106 and is passed through the eyelet of the suturing device 108 to connect the delivery member 106 to the suturing device 108. Cutting the thread releases the suturing device 108 from the delivery member 106. A variety of other means may be used to releasably connect the distal end 138 of the delivery member 106 to the suturing device 108.
[0044] The delivery member 106 slideably moves within the lumen 130 of the elongate member 104. Accordingly, because the delivery member 106 may be positioned to abut and/or to engageably contact the suturing device 108, slideable movement of the delivery member 106 along a longitudinal axis of the elongate member 104 can result in a corresponding movement of the suturing device 108 along the longitudinal axis of the elongate member 104. In one embodiment, extending the delivery member 106 toward the distal end 126 of the elongate .. _.. - 10 -member 104 extends the suturing device 108 toward the distal end 126 of the elongate member 104 and distal to the opening 132 located at the distal end 126 of the elongate member 104.
[0045] FIGS. 3 and 4 depict a schematic cross-sectional view of the distal end 126 of the elongate member 104 according to illustrative embodiments of the invention.
Optionally, as illustrated in FIGS. 3 and 4, the elongate member 104 can include a gate member 137. In one embodiment, the gate member 137 is positioned, as illustrated in FIGS. 3 and 4, at the distal end 126 of the elongate member 104. Alternatively, the gate member 137 may be positioned anywhere along the long axis of the elongate member 104.
[0046] In one embodiment, the gate member 137 is moveable between an extended position, to illustrated in FIG. 3, and a retracted position, illustrated in FIG. 4.
When placed in the extended position, the gate member 137 projects from an inner surface 139 of the wall 128 of the elongate member 104 into the lumen 130 of the elongate member 104, thereby preventing the suturing device 108 from being extended distal to the opening 132 located at the distal end 126 of the elongate member 104.
[0047] In one embodiment, the distal end 126 of the elongate member 104 is designed such that the gate member 137 achieves the extended position unless the physician acts to move the gate member 137 from the extended position by, for example, applying a force to or actuating the gate member 137. For example, the distal end 126 of the elongate member 104 may be made of a shape memory material designed to place the gate member 137 in its extended position absent 2o any forces on, or actuation of, the gate member 137. In one such embodiment, one or more actuating strings 127 extend along a length of the elongate member 104 from the proximal end 124 of the elongate member 104 towards the distal end 126 of the elongate member 104. As illustrated in FIGS. 3 and 4, the one or more actuating strings 127 may be encapsulated within the wall 128 of the elongate member 104 and each one of the actuating strings) 127 may connect at a distal end 129 of the actuating strings) 127 to an end 131 of the gate member 137.
,. .._. _ - 11 -Accordingly, with the gate member 137 in the extended position (FIG. 3), to place the gate member 137 in the retracted position (FIG. 4), the physician pulls on the actuating strings) 127 in the direction of arrow 141 to rotate the gate member 137 away from the lumen 130 of the elongate member 104. When the physician releases the actuating strings) 127, the shape memory material of the distal end 126 of the elongate member 104 returns the gate member 137 to the extended position.
[0048] Alternatively, in another embodiment, the gate member 137 requires actuation to be placed in the extended position. In one such embodiment, the physician places the gate member 137 in the extended position by, for example, rotating the entire, or one or more portions of the, to wall 128 at the distal end 126 of the elongate member 104 towards the lumen 130 of the elongate member 104. For example, the physician employs a controller, as described below, to rotate the gate member 137 between the extended position and the retracted position.
[0049] In one embodiment, as illustrated in FIG. 3, the gate member 137, when placed in the extended position, continuously extends from and around the entire perimeter of the inner surface 139 of the elongate member 104. Alternatively, the gate member 137 may extend from a single portion of the perimeter of the Timer surface 139, or the gate member 137 may intermittently extend from different portions of the perimeter of the inner surface 139 of the elongate member 104.
[0050] With reference to FIG. 4, when the gate member 137 is retracted to the retracted position, 2o the gate member 137 no longer projects into the lumen 130 of the elongate member 104.
Accordingly, with the gate member 137 placed in the retracted position, the suturing device 108 may be extended distal to the opening 132 located at the distal end 126 of the elongate member 104.
[0051] In one embodiment, the elongate member 104 and the delivery member 106 are flexible tubes fabricated from biocompatible materials, such as, for example, polyethylene, polyether-block amide copolymer (e.g., PEBAX°, which is manufactured by Atofina Chemicals of Philadelphia, Pennsylvania), polyurethane, or fluorinated ethylene propylene.
In another embodiment, the elongate member 104 andlor the delivery member 106 are made entirely fiom metal (e.g., stainless steel or Nitinol, which is a nickel-titanium alloy manufactured by Nitinol Devices and Components of Freemont, California). In yet another embodiment, the elongate member 104 and/or the delivery member 106 have a polymer shaft with a metallic tip.
(0052] Referring again to FIG. 2, also illustrated is an exemplary interface 110 that permits, in some embodiments, the first controller 112 and the second controller 114 to communicate with the elongate member 104 and the delivery member 106, respectively. To enable such to communication, the proximal end 124 of the elongate member 104 and the proximal end 136 of the delivery member 106 each connect to the interface 110. The exemplary first controller 112 and the exemplary second controller 114 may, for example, extend, retract, or otherwise manipulate the elongate member 104, including the gate member 137 of the elongate member 104, and the delivery member 106, respectively.
[0053] A single controller could, alternatively, control all functions and operations of the tissue suturing system 100 and the instruments disposed therein. Alternatively, a plurality of controllers (e.g., a distal end controller for extending and retracting the distal end of an instrument, a tip bending controller for altering the angular orientation of a portion of an instnunent, and an extension controller for extending and retracting a component of an 2o instrument) may be provided, each one controlling different components or functions of the tissue suturing system 100, as is known to one skilled in the art. For example, a separate gate member controller may be provided for extending, retracting, or otherwise manipulating the gate member 137 of the elongate member 104. In yet another embodiment, the physician operates the tissue suturing system 100 by extending, retracting, or otherwise manipulating the elongate member 104, the gate member 137 of the elongate member 104, and the delivery device 106 manually, without the use of any controllers.
[0054] FIG. 5 depicts a suturing device 108 in a connected configuration according to an illustrative embodiment of the invention. Referring to FIGS. 2 and 5, the illustrative suturing device 108 includes a first tissue engaging member 140, a second tissue engaging member 142, and a first interconnecting member 144. In one embodiment, the first tissue engaging member 140 includes a first end 146, an opposite, second end 148, and an intermediate portion 147 that is positioned between the first end 146 and the second end 148. Similarly, the second tissue engaging member 142 includes a first end 150, a second end 152 that is opposite to the first end l0 150, and an intermediate portion 151 that is positioned between the first end 150 and the second end 152. For its part, the first interconnecting member 144 includes a first fixed end 154 that is connected to the first tissue engaging member 140, and an opposite, second fixed end 156 that is connected to the second tissue engaging member 142.
[0055] FIG. 6 depicts the tissue suturing system 100 according to another illustrative embodiment of the invention. Referring now to FIGS. 5 and 6, in one embodiment, the first tissue engaging member 140 includes a lumen 157 that extends from the first end 146 to the second end 148 of the first tissue engaging member 140, and the second tissue engaging member 142 includes a lumen 159 that extends from the first end 150 to the second end 152 of the second tissue engaging member 142. Accordingly, in one embodiment, as depicted in FIG. 6, the 2o elongate member 104 may be initially positioned within and through the lumen 159 of the second tissue engaging member 142 and within and through the lumen 157 of the first tissue engaging member 140.
[0056] With reference to FIG. 6, in one embodiment, the delivery member 106 includes a lumen 161 that extends from the proximal end 136 to the distal end 138 of the delivery member 106.
Accordingly, the elongate member 104 may also be initially positioned within and through the lumen 161 of the delivery member 106. In another embodiment, the delivery member 106, the first tissue engaging member 140, and the second tissue engaging member 142 are slideably moved over an outer surface 163 of the wall 128 of the elongate member 104.
Extending the delivery member 106 toward the distal end 126 of the elongate member 104 extends the suturing device 108 toward the distal end 126 of the elongate member 104 and distal to the distal end 126 of the elongate member 104. Additionally, in another embodiment, one or both ends 146, 148 of the first tissue engaging member 140 and/or one or both ends 150, 152 of the second tissue engaging member 142 are rounded, tapered, or beveled to facilitate the passage of the first tissue engaging member 140 and/or the second tissue engaging member 142 through a patient's tissues.
[0057] Referring again to FIG. 5, in one embodiment, as shov~m, the first fixed end 154 of the first interconnecting member 144 is connected to the first tissue engaging member 140 at a point located between the first end 146 and the second end 148 of the first tissue engaging member 140, rather than at one of the opposing ends 146, 148 of the first tissue engaging member 140.
Accordingly, in such an embodiment, the first fixed end 154 of the first intereconnecting member 144 is connected to the intermediate portion 147 of the first tissue engaging member 140 and the opposing ends 146, 148 of the first tissue engaging member 140 are both free ends. .
Alternatively, in another embodiment, the first fixed end 154 of the first interconnecting member 144 is comiected to the first tissue engaging member 140 either at the first end 146 or at the second end 148 of the first tissue engaging member 140. Accordingly, in such an embodiment, one of the first end 146 and the second end 148 of the first tissue engaging member 140 is a fixed end. In a similar fashion, the second fixed end 156 of the first interconnecting member 144 may be connected to the second tissue engaging member 142 at a point located between the first end 150 and the second end 152 of the second tissue engaging member 142 (i.
e., the first interconnecting member 144 may be connected to the intermediate portion 151 of the second tissue engaging member 142), or, alternatively, at one of the opposing ends 150, 152 of the second tissue engaging member 142.
[005] In one embodiment, the first interconnecting member 144 is connected at its first fixed end 154 to the first tissue engaging member 140 and at its second fixed end 156 to the second tissue engaging member 142 by, for example, an adhesive, such as a glue.
Alternatively, the first interconnecting member 144 includes a first hinge 158 at its first fixed end 154 and a second hinge 160 at its second fixed end 156. In one such embodiment, the first hinge 158 connects the first interconnecting member 144 to the first tissue engaging member 140 and the second hinge 160 connects the first interconnecting member 144 to the second tissue engaging member 142.
to In one embodiment, the first lunge 158 and the second hinge 160 allow for rotational movement of the first tissue engaging member 140 and the second tissue engaging member 142, respectively, relative to each other and relative to the first interconnecting member 144.
[0059] In one embodiment, the suturing device 108 is pre-assembled (e.g., manufactured) so that the first interconnecting member 144 continuously connects the first tissue engaging member 140 to the second tissue engaging member 142. In other words, the physician need not, at any point during his or her use of the suturing system 100, connect one portion of the first interconnecting member 144 to another portion of the first interconnecting member 144, or connect either one of the two tissue engaging members 140, 142 to the first intercomlecting member 144. Rather, the suturing device 108 is insertable into a patient in its connected 2o configuration, illustrated in, and described with respect to, for example, FIG. 5.
[0060] In one embodiment, the first interconnecting member 144 is made from a flexible yet resilient material, allowing the first interconnecting member 144 to alternate between a deformed position (e.g., a bent position), as illustrated in FIGS. 2 and 6, and an unstressed position, such as the straight configuration illustrated in FIG. 5. In one embodiment, the first interconnecting member 144 alternates between the deformed and unstressed positions through the application .. _.. - 16 -and removal of, respectively, a force. Referring to FIG. 5, in the unstressed position of the first interconnecting member 144, a longitudinal axis of the first tissue engaging member 140 and a longitudianal axis of the second tissue engaging member 142 are, in one embodiment, each substantially perpendicular to a longitudinal axis of the first interconnecting member 144. With reference to FIGS. 2 and 6, in the deformed position of the first interconnecting member 144, a longitudinal axis of the first tissue engaging member 140 and a longitudinal axis of the second tissue engaging member 142 are, in one embodiment, each substantially parallel to the longitudinal axis of the first interconnecting member 144.
[0061] Referring to FIG. 2, in operation, in one embodiment, the suturing device 108 is initially to positioned within the lumen 130 of the elongate member 104 with its first interconnecting member 144 in the deformed position. Moreover, in one embodiment, the wall 128 of the elongate member 104 constrains the first interconnecting member 144 of the suturing device 108 in the deformed position while the suturing device 108 is located within the lumen 130 of the elongate member 104. Once the suturing device 108 is advanced distally to exit through the 15 opening 132 at the distal end 126 of the elongate member 104, the resiliency of the first interconnecting member 144 causes, in one embodiment, the first interconnecting member 144 of the suturing device 108 to regain its unstressed position, illustrated in FIG. 5.
[0062] Exemplary resilient materials from which the first interconnecting member 144 can be manufactured include bioabsorbable materials such as, but not exclusively, polylactic acid 20 (PLA), polyethylene glycol (PEG), polycaprolactone (PCL), polyglycolic acid (PGA), or magnesium, non-resorbable materials such as, but not exclusively, a metal (e.g., nitinol) or a polymer (e.g., urethane), and/or rubber.
[0063] In some embodiments of the invention, the first interconnecting member 144 of the suturing device 108 possesses elastic properties. For example, in one embodiment, the first 25 interconnecting member 144 can be stretched, and thereafter returned to its original state when the stretching force is removed. More particularly, in one embodiment, as the first interconnecting member 144 is stretched, moving the first tissue engaging member 140 away from the second tissue engaging member 142, a restoring force is generated in the first interconnecting member 144. The restoring force acts to pull the first tissue engaging member 140 back towards the second tissue engaging member 142 when the stretching force is removed.
Exemplary elastic materials from which the first interconnecting member 144 can be manufactured include bioabsorbable materials such as, but not exclusively, polylactic acid (PLA), polyethylene glycol (PEG), polycaprolactone (PCL), or polyglycolic acid (PGA), non-resorbable materials such as, but not exclusively, a polymer or a polymer blend (e.g., urethane), l0 and/or rubber.
[0064] Referring now to FIG. 5, in one embodiment, the first tissue engaging member 140 and/or the second tissue engaging member 142 are substantially cylindrical.
Alternatively, the first tissue engaging member 140 and the second tissue engaging member 142 may have other shapes (e.g., a rectangular prism). In another embodiment, one or both of the first tissue engaging member 140 and the second tissue engaging member 142 has/have an atraumatic structure, i.e., is/are devoid of any outward projections or protrusions that might cause injury or trauma to a patient's tissue. There is, therefore, no impediment to contacting a patient's tissue directly and intimately with the first tissue engaging member 140 and/or the second tissue engaging member 142. For example, in one embodiment where the tissue engaging members 140, 142 are atraumatic, one or both of the opposing ends 146, 148 of the first tissue engaging member 140 and/or one or both of the opposing ends 150, 152 of the second tissue engaging member 142 are rounded.
[0065] In one embodiment, the first interconnecting member 144 has a length of between about 1.0 mm and about 20.0 rrun and a cross-sectional diameter between about 0.01 mm and about 2.0 nun. In another embodiment, a tissue engaging member, for example the first tissue engaging .. .. -1g-member 140, has a length 162 from about 1.0 mm to about 20.0 mm and a cross-sectional diameter 164 from about 0.05 mm to about 5.0 mm.
[0066] FIG. 7 depicts the suturing device 108 according to another illustrative embodiment of the invention. According to the illustrative embodiment, the suturing device 108 also includes one or more third tissue engaging members 168. For example, the suturing device 108 includes two third tissue engaging members 168a, 168b, one of which is connected to the first fixed end 154 of the first interconnecting member 144 and another of which is connected to the second fixed end 156 of the first interconnecting member 144. In one embodiment, a midpoint 170 along the longitudinal axis of the first tissue engaging member 140 is connected to a midpoint io 172 along the longitudinal axis of a third tissue engaging member 168a. In one embodiment, the first tissue engaging member 140 and that third tissue engaging member 168a are delivered, through the lumen 130 of the elongate member 104, co-axially. Upon exiting the opening 132 at the distal end 126 of the elongate member 104, the first tissue engaging member 140 and that third tissue engaging member 168a rotate, for example, relative to one another such that, in one embodiment, the longitudinal axis of the first tissue engaging member 140 is oriented substantially perpendicular to the longitudinal axis of that third tissue engaging member 168a, thereby forming a cross or an X-shape. Similarly, a midpoint 174 along the longitudinal axis of the second tissue engaging member 142 may be connected to a midpoint 176 along the longitudinal axis of another third tissue engaging member 168b. In one embodiment, the second 2o tissue engaging member 142 and that third tissue engaging member 168b axe delivered, through the lumen 130 of the elongate member 104, co-axially. Upon exiting the opening 132 at the distal end 126 of the elongate member 104, the second tissue engaging member 142 and that third tissue engaging member 168b rotate, for example, relative to one another such that, in one embodiment, the longitudinal axis of the second tissue engaging member 142 is oriented substantially perpendicular to the longitudinal axis of that third tissue engaging member 168b, thereby forming a cross or an X-shape. Alternatively, in other embodiments, when the suturing device 108 exits the opening 132 at the distal end 126 of the elongate member 104, the longitudinal axis of the first tissue engaging member 140 and the longitudinal axis of the second tissue engaging member 142 are each oriented at an angle between 0 degrees and 180 degrees relative to the longitudinal axis of their respective third tissue engaging member 168a, 168b.
[0067] FIG. 8 depicts the suturing device 108 according to yet another illustrative embodiment of the invention. According to the illustrative embodiment, the suturing device 108 further includes one or more second interconnecting members 178. For example, in one embodiment, the suturing device 108 includes a chain of second interconnecting members 178. In one such to embodiment, at least one of the second intercomiecting members 178 is connected to either the first tissue engaging member 140 or the second tissue engaging member 142. For example, as illustrated in FIG. 8, a second interconnecting member 178A is connected to the second tissue engaging member 142. Moreover, each one of the second interconnecting members 178 in the chain may be separated from an adjacent second interconnecting member 178 by a third tissue engaging member 168. For example, as illustrated in FIG. 8, a second interconnecting member 178A is separated from an adjacent second interconnecting member 178B by a third tissue engaging member 168A. Accordingly, the suturing device 108 of the invention may consist of a series of alternating tissue engaging members and interconnecting members. Any number of alternating tissue engaging members and interconnecting members may be connected in series to form the chain. Moreover, in general, the second interconnecting members 178 may include some or all of the properties of the first interconnecting member 144 described above, including, for example, the resiliency of the first interconnecting member 144.
Accordingly, the second interconnecting members 178 may also alternate between a deformed position and an unstressed position.
[0068] FIG. 9 depicts the suturing device 108 according to still another illustrative embodiment of the invention. According to the illustrative embodiment, two or more interconnecting members may connect adjacent tissue engaging members. For example, both the first interconnecting member 144 and a second interconnecting member 178E may connect the first tissue engaging member 140 to the second tissue engaging member 142.
Similarly, as another example, three second interconnecting members 178B, 178F, 1786 may connect two adjacent third tissue engaging members 168A, 168B.
[0069] FIG. 10 depicts a suturing device 108' according to another illustrative embodiment of the invention. The exemplary suturing device 108' includes a first interconnecting member 144', a first tissue engaging member 140', and a second tissue engaging member 142' similar to those described above. In one embodiment, the suturing device 108' additionally includes a tightening mechanism 180 connected to the first intercomiecting member 144'. The first interconnecting member 144' may be, for example, a thread. Following implantation of the suturing device 108' in the patient's tissues, the tightening mechanism 180 may be used to remove a slack in the first interconnecting member 144' between the first tissue engaging member 140' and the second tissue engaging member 142'. In one embodiment, for example, the tightening mechanism 180 is a ratchet. Alternatively, in other embodiments, the tightening mechanism 180 is a wire-tie, a slip-knot, or a screw mechanism.
[0070] In one embodiment, referring still to FIG. 10, the first tissue engaging member 140' and/or the second tissue engaging member 142' includes an anchor 182, such as, for example, a spiral tissue anchor 179. Accordingly, the first tissue engaging member 140' and/or the second tissue engaging member 142' may be screwed into a patient's tissues.
Alternatively, in another embodiment, the first tissue engaging member 140' and/or the second tissue engaging member 142' includes a differently shaped anchor 182 for implanting the tissue engaging member 140', 142' into the patient's tissue. For example, the first tissue engaging member 140' and/or the second tissue engaging member 142' may include a barbed tissue anchor 181, as illustrated in FIG. 11. Accordingly, the barbed tissue anchor 181 of the first tissue engaging member 140' and/or the second tissue engaging member 142' may be pushed into a patient's tissues to secure the engaging member 140', 142' in the patient's tissues.
[0071] Some or all of the tissue engaging members 140, 140', 142, 142', 168, the interconnecting members 144, 144', 178, and the tightening mechanism 180 may be manufactured from a bioabsorbable material that, following placement in the patient's body, biodegrades over time and is absorbed into the patient's body, such as, for example, polylactic acid (PLA), polyethylene glycol (PEG), polycaprolactone (PCL), polyglycolic acid (PGA), or to magnesium. In other embodiments, some or all of the tissue engaging members 140, 140', 142, 142', 168, the interconnecting members 144, 144', 178, and the tightening mechanism 180 may be manufactured from a biological material (e.g., an extracellular matrix material) that allows for tissue ingrowth when the suturing device 108, 108' is implanted within a patient's tissues. In yet other'embodiments, some or all of the tissue engaging members 140, 140', 142, 142', 168, the interconnecting members 144, 144', 178, and the tightening mechanism 180 are coated andlor impregnated with a material (e.g.'; a reactive material) for stimulating tissue growth. In one embodiment, the growth stimulating material is collagen. In another embodiment, the growth stimulating material is a growth factor, such as a vascular endothelial growth factor, a basic fibro growth factor, or an angiogenic growth factor. In yet another embodiment, the growth 2o stimulating material is a pharmacological agent for stimulating tissue growth, such as, for example, cells or genes. Alternatively, in still another embodiment, the growth stimulating material is an irritant for encouraging an inflammatory response, such as, for example, cotton seed oil or alcohol.
[0072] Materials that are not bio-absorbable could, alternatively, be used to manufacture different parts of the suturing device 108, 108'. The tissue engaging members 140, 140', 142, 142', 168 andlor the tightening mechanism 180 could, for example, be manufactured using a polymer material, (e.g., polyethylene, nylon, polypropylene, polyester, or polyurethane), a shape memory material, or a metal. For their part, the interconnecting members 144, 144', 178 could, for example, be manufactured using a polymer material, (e.g., polyethylene or polyurethane), a shape memory material, a metal, a thread, a spring, or an elastomer. For example, the tissue engaging members 140, 140', 142, 142', 168, arid the interconnecting members 144, 144', 178 could be manufactured using a nickel-titanium alloy, such as Nitinol. As another example, the tissue engaging members 140, 140', 142, 142', 168, and the interconnecting members 144, 144', 178 can be manufactured as am integral unit by, for example, molding or stamping them from a l0 single piece of material, such as a polymer.
[0073] In yet another embodiment, some or all of the tissue engaging members 140, 140', 142, 142', 168, the interconnecting members 144, 144', 178, and the tightening mechanism 180 are coated with a material that reduces thrombosis, such as, for example, heparin.
In still another embodiment, some or all of the tissue engaging members 140, 140', 142, 142', 168, the interconnecting members 144, 144', 178, and the tightening mechanism 180 include a radiopaque material.
[0074] In another aspect, the invention provides a method for suturing tissue.
FIGS. 12A-12D
illustrate one embodiment of a method for percutaneously suturing closed a patent foramen ovale 52 in the intraatrial septum in the heart of a patient in accordance with the invention. Referring 2o first to FIG. 12A, the physician positions a distal end 183 of a tissue suturing system, such as the tissue suturing system 100 of FIG. 2, within the right atrium 56 of the patient in proximity to the septum secundum 62.
[0075] Optionally, as illustrated in FIG. 12A, the physician also employs a tissue stabilization device 184 with the tissue suturing system 100. In one such embodiment, the tissue stabilization device 184 is connected to a catheter 185. The catheter 185 includes a proximal end (not ._ - 23 -shown), a distal end 187, a lumen 189 that extends from the proximal end to the distal end 187, and an opening 191 that is positioned at the distal end 187 of the catheter 185 and that is in fluid communication with the lumen 189 of the catheter 185. In one embodiment, as illustrated, the catheter 185 is positioned within the lumen 120 of the sheath 102. The elongate member 104, the delivery member 106, and the suturing device 108 are positioned within the lumen 189 of the catheter 185.
[0076] In one embodiment, the physician positions the tissue stabilization device 184 within and through the patent foramen ovate 52 between the septum secundmn 62 and the septum primum 60 of the patient's heart. The tissue stabilization device 184 is used by the physician to, for l0 example, limit movement of the septum secundum 62 and the septum primum 60 prior to forming, as explained below, holes through the septum secundum 62 and the septum primum 60 with the cutting member 134 of the elongate member 104. The tissue stabilization device 184 also serves to position the distal end 187 of the catheter 185 in the area where the septum secundum 62 and the septum primum 60 overlap. Accordingly, when the elongate member 104 15 is extended to exit through the opening 191 at the distal end 187 of the catheter 185, the cutting member 134 of the elongate member 104 pierces holes through the septum secundum 62 and the septum primum 60 in the area where they overlap. In accordance with the method further described below, the suturing device 108 is thereby placed through the septa 60, 62 in the area where they overlap.
2o [0077] Exemplary tissue stabilization devices and flexible members suitable for stabilizing cardiac tissues in a patient and for placing the elements described above in the area where the septum secundum 62 and the septum primum 60 overlap include those described in United States .
patent application Serial No. 10/660,444, the disclosure of which is hereby incorporated herein by reference in its entirety. For example, the tissue stabilization device 184 may: i) be a flexible 25 coil having a spiral shape, illustrated in FIG. 12A, ii) include three flexible hexagonal members forming, generally, a planar array, iii) include two flexible members, each one of which includes a leg, such as a wire, that is pre-shaped to articulate one or more times upon exit from a lumen, iv) include two flexible members, each one of which includes a loop section, or v) be a single flexible member that forms a closed loop.
[0078] Alternatively, in another embodiment, the physician does not employ the tissue stabilization device 184 in suturing the patent foramen ovate 52. Accordingly, while FIGS.
12B-12D do not, for the purposes of simplifying and clarifying the drawings, illustrate the tissue stabilization device 184, it is understood that the tissue stabilization device may or may not be present in practice.
[0079] Referring now to FIG. 12B, the physician extends, in one embodiment, the elongate member 104 distally, so that the cutting member 134 of the elongate member 104 contacts a tissue surface 186 of the septum secundum 62 at a point where the septum secundum 62 overlaps the septum primum 60. By continuing to advance the elongate member 104, the physician forms a first hole 188 in the septum secundum 62 and, subsequently, a second hole 190 in the overlapping septum primum 60.
[0080] Referring now to FIG. 12C, with the distal end 126 of the elongate member 104 in the left atrium 58, the delivery member 106 is advanced toward the distal end 126 of the elongate member 104 until the first tissue engaging member 140 exits the opening 132 at the distal end 126 of the elongate member 104. Once the first tissue engaging member 140 exits the opening , 132, the resiliency of the first interconnecting member 144 causes the first fixed end 154 of the first interconnecting member 144 to return to an unstressed (e.g., a straight) position, such that the longitudinal axis of the first tissue engaging member 140 is substantially perpendicular to the longitudinal axis of the first interconnecting member 144.
[0081] RefeiTing now to FIG. 12D, the physician then retracts the elongate member 104 proximally back through the second hole 190 and the first hole 188, such that the first tissue engaging member 140 is located adjacent a surface 192 of the septum primum 60.
The physician continues to retract the elongate member 104 until the distal end 126 of the elongate member 104 is positioned in the right atrium 56. The delivery member 106 is then further advanced distally until the second tissue engaging member 142 exits the opening 132 at the distal end 126 of the elongate member 104. Once the second tissue engaging member 142 exits the opening 132, the resiliency of the first interconnecting member 144 causes the second fixed end 156 of the first interconnecting member 144 to return to an unstressed (e.g., a straight) position, such that the longitudinal axis of the second tissue engaging member 142 is substantially perpendicular to the longitudinal axis of the first interconnecting member 144. The second tissue engaging member l0 142 is thereby positioned adjacent a tissue surface 186 of the septum secundum 62. Configured as such, the suturing device 108 holds the septum primum 60 and the septum secundum 62 between the first tissue engaging member 140 and the second tissue engaging member 142.
[0082] FIG. 13 depicts a suturing device 108 implanted into the intraatrial septum in the heart of a patient in accordance with another embodiment of the invention. According to the illustrative 15 embodiment, rather than creating the first hole 188 through the septum secundum 62 and the second hole 190 through the septum primum 60 at a point where the septum secundum 62 and the septum primum 60 overlap, as described above, the physician creates the holes 188, 190 at a point where the septum secundum 62 and the septum primum 60 do not overlap.
For example, the physician uses the cutting member 134 to create the first hole 188 through the septum 2o secundum 62, positions the first tissue engaging member 140 in the left atrium 58 adjacent a tissue surface of the septum secundum 62, proximally withdraws the elongate member 104 back into the right atrium 56, uses the cutting member 134 to create the second hole 190 through the septum primum 60, positions the second tissue engaging member 142 in the left atrium 58 adjacent a tissue surface of the septum primum 60, and proximally withdraws the elongate 25 member 104 back into the right atrium 56 for eventual removal from the patient's body. The ._ ...... .. _ - 26 -suturing device 108 thus captures the septum primum 60 and the septum secundum 62 as illustrated in FIG. 13, without occupying a position in the tunnel of the patent foramen ovate 52.
Alternatively, in another embodiment, the physician creates the holes 188, 190 in the septum secundum 62 and the septum primum 60 in the opposite order.
[0083] FIG. 14 depicts a suturing device 108' implanted into the intraatrial septum in the heart of a patient in accordance with another embodiment of the invention. According to the illustrative embodiment, rather than forming holes 188, 190 through the septum secundum 62 and the septum primum 60 to access the left atrium 58, the physician advances the spiral tissue anchors 179 (or the barbed tissue anchors 181) of the tissue engaging members 140', 142' into to the right atrial wall of the septum primum 60 and the septum secundum 62.
In one such embodiment, the distal end 126 of the elongate member 104 is adapted to engage the tissue engaging members 140', 142' as they are advanced by the delivery member 106 to the distal end 126 of the elongate member 104. Once a tissue engaging member 140', 142' is engaged by the distal end 126 of the elongate member 104, the physician then rotates the elongate member 104 to screw the spiral tissue anchor 179 of the tissue engaging member 140', 142' into the patient's tissue, or, alternatively, the physician advances the elongate member 104 to push the barbed tissue anchor 181 of the tissue engaging member 140', 142' into the patient's tissue.
Accordingly, the suturing device 108' captures the septum primum 60 and the septum secundum 62 as illustrated in FIG. 14. Optionally, the physician may then use the tightening mechanism 180 to remove any slack in the first interconnecting member 144' between the first tissue engaging member 140' and the second tissue engaging member 142'.
[0084] In other embodiments, to deliver a suturing device 108, 108' that includes a series of alternating tissue engaging members and interconnecting members, as illustrated in FIGS. 8 and 9, the physician repeats the steps described above with reference to either FIGS. 12A-12D, FIG.
13, or FIG. 14. In some such embodiments, to distally advance the suturing device 108, 108' through the lumen 130 of the elongate member 104, the delivery member 106 abuts the distal most tissue engaging member (e.g., the third tissue engaging member 168D in FIGS. 8 and 9) in the series of alternating tissue engaging members and interconnecting members.
[0085] It should be understood that the order of the steps in the above described methods and/or the order for performing certain actions is immaterial so long as the invention remains operable.
Moreover, two or more steps or actions may be conducted simultaneously.
[0086] Certain embodiments of the present invention were described above. It is, however, expressly noted that the present invention is not limited to those embodiments, but rather the intention is that additions and modifications to what was expressly described herein are also included within the scope of the invention. Moreover, it is to be understood that the features of the various embodiments described herein were not mutually exclusive and can exist in various combinations and permutations, even if such combinations or permutations were not made express herein, without departing from the spirit and scope of the invention.
In fact, variations, modifications, and other implementations of what was described herein will occur to those of ordinaxy skill in the art without departing from the spirit and the scope of the invention. As such, the invention is not to be defined only by the preceding illustrative description.
[0087] What is claimed is:
[0028] FIG. 9 is a schematic side view of a suturing device according to another illustrative .
embodiment of the invention.
[0029] FIG. 10 is a schematic side view of a suturing device according to another illustrative embodiment of the invention.
[0030] FIG. 11 is a schematic side view of a suturing device according to another illustrative embodiment of the invention.
[0031] FIGS. 12A-12D illustrate the stages in one embodiment of a method for suturing the l0 intraatrial septum in the heart of a patient in accordance with the invention.
[0032] FIG. 13 illustrates a suturing device implanted into the intraatrial septum in the heart of a patient in accordance with another embodiment of the invention.
[0033] FIG. 14 illustrates a suturing device implanted into the intraatrial septum in the heart of a patient in accordance with another embodiment of the invention.
Description [0034] The present invention relates to devices, systems, and methods for percutaneously suturing together biological material, such as layers of tissue. For example, in accordance with the invention, the septum primum and the septum secundum of a patent foramen ovate are sutured together.
2o [0035] Throughout the description, where devices are described as having, including, or comprising specific components, or where methods are described as having, including, or comprising specific method steps, it is contemplated that the devices of the present invention also consist essentially of, or consist of, the recited components, and that the methods of the present invention also consist essentially of, or consist of, the recited method steps.
[0036] In broad overview, a suturing device of the invention includes, in one embodiment, two tissue engaging members interconnected by an interconnecting member. In order to suture together two layers of tissue, the suturing device of the invention is, in one embodiment, placed through holes formed in the two layers of tissue. Each of the two tissue engaging members then engages one of the two layers of tissue. Optionally, a suturing system of the invention includes a cutting member for forming the holes in the layers of tissue.
[0037] FIG. 1 depicts a cutaway view of a heart 50, including an exemplary abnormal opening, a patent foramen ovale 52, that can be corrected by the devices, systems, and methods of the present invention. The view of the heart 50 depicted in FIG. 1 includes a septum 54 that divides a right atrium 56 from a left atrium 58. The septum 54 includes a septum primum 60 and a septum secundum 62. The patent foramen ovate 52 is located between the septum primum 60 and the septum secundum 62. The patent foramen ovate 52 provides an undesirable fluid communication between the right atrium 56 and the left atrium 58 and, under certain conditions, allows for the shunting of blood from the right atrium 56 to the left atrium 58. If the patent foramen ovate 52 is not closed or obstructed in some manner, a patient is placed at high risk for an embolic stroke.
[0038] FIG. 2 depicts a tissue suturing system 100 according to an illustrative embodiment of the invention. In one embodiment, the tissue suturing system 100 includes a sheath 102, an elongate member 104, a delivery member 106, a suturing device 108, an interface 110, a first controller 112, and a second controller 114.
[0039] In one embodiment, the sheath 102 includes a proximal end 116 (i. e., an end that is closest to a physician when the physician is operating the tissue suturing system 100) and an opposite, distal end 118. In one embodiment, the proximal end 116 of the sheath 102 is connected to the interface 110. In another embodiment, the sheath 102 defines a lumen 120 that extends from the proximal end 116 to the distal end 118 of the sheath 102, and an opening 122 _g_ located at the distal end 118 of the sheath 102. The opening 122 is in fluid communication with the lumen 120 of the sheath 102. In one embodiment, the sheath 102 is a transseptal sheath, such as, for example, item number RCF-10.0-38-80-J-RB Large Check-Flo ' Blue Introducer Set, which is manufactured by Cook Incorporated of Bloomington, Indiana.
[0040] With continued reference to FIG. 2, at least partially disposed within the lumen 120 of the sheath 102 is the elongate member 104. The elongate member 104 includes a proximal end 124, an opposite, distal end 126, and a wall 128 extending from the proximal end 124 to the distal end 126. In one embodiment, the wall 128 of the elongate member 104 defines a lumen 130 that extends from the proximal end 124 to the distal end 126 of the elongate member 104, to and an opening 132 at the distal end 126 of the elongate member 104. In another embodiment, the elongate member 104 includes, at its distal end 126, a cutting member 134 that is used, for example, to create one or more holes through a patient's tissues. The cutting member 134 may be, for example, a sharp point or protrusion formed at the distal end 126 of the elongate member 104 by, for example, trimming the distal end 126 of the elongate member 104 at an angle from a line 133 drawn perpendicular to the long axis of the elongate member 104.
[0041] The elongate member 104 according to the invention can achieve an extended position and a retracted position. Referring to FIG. 2, in the extended position of the elongate member 104, a distal portion 135 of the elongate member 104 is positioned distal to the distal end 118 of the sheath 102. In the retracted position of the elongate member 104, the entire elongate member 104 is positioned proximal to the distal end 118 of the sheath 102, i. e., within the lumen 120 of the sheath 102 (not shown). The sheath 102 may thus enclose the cutting member 134 of the elongate member 104 while the physician inserts the tissue suturing system 100 into the heart of a patient.
[0042] In one embodiment, the elongate member 104 is reciprocally moved between the extended and retracted positions by slideable movement of the elongate member 104 within the lumen 120 of the sheath 102 along the longitudinal axis of the sheath 102.
Alternatively, the elongate member 104 may be stationary and may be alternated between the extended position and the retracted position by proximally withdrawing the sheath 102 over the elongate member 104 to extend the elongate member 104, and by distally advancing the sheath 102 over the elongate member 104 to retract the elongate member 104.
[0043] Referring still to FIG. 2, in one embodiment, the delivery member 106 and the suturing device 108 axe iiutially disposed within the lmnen 130 of the elongate member 104. The exemplary delivery member 106 includes a proximal end 136 and an opposite, distal end 138.
The distal end 138 of the delivery member 106 may be positioned adjacent the suturing device l0 108 to engageably contact the suturing device 108. In one embodiment, the distal end 138 of the delivery member 106 is releasably connected to the suturing device 108. For example, the distal end 138 of the delivery member 106 may include a mechanical claw (not shown) for grasping and releasing the suturing device 108. Alternatively, in another embodiment, the suturing device 108 includes an eyelet (not shown). In one such embodiment, thread (not shown) is connected to the delivery member 106 and is passed through the eyelet of the suturing device 108 to connect the delivery member 106 to the suturing device 108. Cutting the thread releases the suturing device 108 from the delivery member 106. A variety of other means may be used to releasably connect the distal end 138 of the delivery member 106 to the suturing device 108.
[0044] The delivery member 106 slideably moves within the lumen 130 of the elongate member 104. Accordingly, because the delivery member 106 may be positioned to abut and/or to engageably contact the suturing device 108, slideable movement of the delivery member 106 along a longitudinal axis of the elongate member 104 can result in a corresponding movement of the suturing device 108 along the longitudinal axis of the elongate member 104. In one embodiment, extending the delivery member 106 toward the distal end 126 of the elongate .. _.. - 10 -member 104 extends the suturing device 108 toward the distal end 126 of the elongate member 104 and distal to the opening 132 located at the distal end 126 of the elongate member 104.
[0045] FIGS. 3 and 4 depict a schematic cross-sectional view of the distal end 126 of the elongate member 104 according to illustrative embodiments of the invention.
Optionally, as illustrated in FIGS. 3 and 4, the elongate member 104 can include a gate member 137. In one embodiment, the gate member 137 is positioned, as illustrated in FIGS. 3 and 4, at the distal end 126 of the elongate member 104. Alternatively, the gate member 137 may be positioned anywhere along the long axis of the elongate member 104.
[0046] In one embodiment, the gate member 137 is moveable between an extended position, to illustrated in FIG. 3, and a retracted position, illustrated in FIG. 4.
When placed in the extended position, the gate member 137 projects from an inner surface 139 of the wall 128 of the elongate member 104 into the lumen 130 of the elongate member 104, thereby preventing the suturing device 108 from being extended distal to the opening 132 located at the distal end 126 of the elongate member 104.
[0047] In one embodiment, the distal end 126 of the elongate member 104 is designed such that the gate member 137 achieves the extended position unless the physician acts to move the gate member 137 from the extended position by, for example, applying a force to or actuating the gate member 137. For example, the distal end 126 of the elongate member 104 may be made of a shape memory material designed to place the gate member 137 in its extended position absent 2o any forces on, or actuation of, the gate member 137. In one such embodiment, one or more actuating strings 127 extend along a length of the elongate member 104 from the proximal end 124 of the elongate member 104 towards the distal end 126 of the elongate member 104. As illustrated in FIGS. 3 and 4, the one or more actuating strings 127 may be encapsulated within the wall 128 of the elongate member 104 and each one of the actuating strings) 127 may connect at a distal end 129 of the actuating strings) 127 to an end 131 of the gate member 137.
,. .._. _ - 11 -Accordingly, with the gate member 137 in the extended position (FIG. 3), to place the gate member 137 in the retracted position (FIG. 4), the physician pulls on the actuating strings) 127 in the direction of arrow 141 to rotate the gate member 137 away from the lumen 130 of the elongate member 104. When the physician releases the actuating strings) 127, the shape memory material of the distal end 126 of the elongate member 104 returns the gate member 137 to the extended position.
[0048] Alternatively, in another embodiment, the gate member 137 requires actuation to be placed in the extended position. In one such embodiment, the physician places the gate member 137 in the extended position by, for example, rotating the entire, or one or more portions of the, to wall 128 at the distal end 126 of the elongate member 104 towards the lumen 130 of the elongate member 104. For example, the physician employs a controller, as described below, to rotate the gate member 137 between the extended position and the retracted position.
[0049] In one embodiment, as illustrated in FIG. 3, the gate member 137, when placed in the extended position, continuously extends from and around the entire perimeter of the inner surface 139 of the elongate member 104. Alternatively, the gate member 137 may extend from a single portion of the perimeter of the Timer surface 139, or the gate member 137 may intermittently extend from different portions of the perimeter of the inner surface 139 of the elongate member 104.
[0050] With reference to FIG. 4, when the gate member 137 is retracted to the retracted position, 2o the gate member 137 no longer projects into the lumen 130 of the elongate member 104.
Accordingly, with the gate member 137 placed in the retracted position, the suturing device 108 may be extended distal to the opening 132 located at the distal end 126 of the elongate member 104.
[0051] In one embodiment, the elongate member 104 and the delivery member 106 are flexible tubes fabricated from biocompatible materials, such as, for example, polyethylene, polyether-block amide copolymer (e.g., PEBAX°, which is manufactured by Atofina Chemicals of Philadelphia, Pennsylvania), polyurethane, or fluorinated ethylene propylene.
In another embodiment, the elongate member 104 andlor the delivery member 106 are made entirely fiom metal (e.g., stainless steel or Nitinol, which is a nickel-titanium alloy manufactured by Nitinol Devices and Components of Freemont, California). In yet another embodiment, the elongate member 104 and/or the delivery member 106 have a polymer shaft with a metallic tip.
(0052] Referring again to FIG. 2, also illustrated is an exemplary interface 110 that permits, in some embodiments, the first controller 112 and the second controller 114 to communicate with the elongate member 104 and the delivery member 106, respectively. To enable such to communication, the proximal end 124 of the elongate member 104 and the proximal end 136 of the delivery member 106 each connect to the interface 110. The exemplary first controller 112 and the exemplary second controller 114 may, for example, extend, retract, or otherwise manipulate the elongate member 104, including the gate member 137 of the elongate member 104, and the delivery member 106, respectively.
[0053] A single controller could, alternatively, control all functions and operations of the tissue suturing system 100 and the instruments disposed therein. Alternatively, a plurality of controllers (e.g., a distal end controller for extending and retracting the distal end of an instrument, a tip bending controller for altering the angular orientation of a portion of an instnunent, and an extension controller for extending and retracting a component of an 2o instrument) may be provided, each one controlling different components or functions of the tissue suturing system 100, as is known to one skilled in the art. For example, a separate gate member controller may be provided for extending, retracting, or otherwise manipulating the gate member 137 of the elongate member 104. In yet another embodiment, the physician operates the tissue suturing system 100 by extending, retracting, or otherwise manipulating the elongate member 104, the gate member 137 of the elongate member 104, and the delivery device 106 manually, without the use of any controllers.
[0054] FIG. 5 depicts a suturing device 108 in a connected configuration according to an illustrative embodiment of the invention. Referring to FIGS. 2 and 5, the illustrative suturing device 108 includes a first tissue engaging member 140, a second tissue engaging member 142, and a first interconnecting member 144. In one embodiment, the first tissue engaging member 140 includes a first end 146, an opposite, second end 148, and an intermediate portion 147 that is positioned between the first end 146 and the second end 148. Similarly, the second tissue engaging member 142 includes a first end 150, a second end 152 that is opposite to the first end l0 150, and an intermediate portion 151 that is positioned between the first end 150 and the second end 152. For its part, the first interconnecting member 144 includes a first fixed end 154 that is connected to the first tissue engaging member 140, and an opposite, second fixed end 156 that is connected to the second tissue engaging member 142.
[0055] FIG. 6 depicts the tissue suturing system 100 according to another illustrative embodiment of the invention. Referring now to FIGS. 5 and 6, in one embodiment, the first tissue engaging member 140 includes a lumen 157 that extends from the first end 146 to the second end 148 of the first tissue engaging member 140, and the second tissue engaging member 142 includes a lumen 159 that extends from the first end 150 to the second end 152 of the second tissue engaging member 142. Accordingly, in one embodiment, as depicted in FIG. 6, the 2o elongate member 104 may be initially positioned within and through the lumen 159 of the second tissue engaging member 142 and within and through the lumen 157 of the first tissue engaging member 140.
[0056] With reference to FIG. 6, in one embodiment, the delivery member 106 includes a lumen 161 that extends from the proximal end 136 to the distal end 138 of the delivery member 106.
Accordingly, the elongate member 104 may also be initially positioned within and through the lumen 161 of the delivery member 106. In another embodiment, the delivery member 106, the first tissue engaging member 140, and the second tissue engaging member 142 are slideably moved over an outer surface 163 of the wall 128 of the elongate member 104.
Extending the delivery member 106 toward the distal end 126 of the elongate member 104 extends the suturing device 108 toward the distal end 126 of the elongate member 104 and distal to the distal end 126 of the elongate member 104. Additionally, in another embodiment, one or both ends 146, 148 of the first tissue engaging member 140 and/or one or both ends 150, 152 of the second tissue engaging member 142 are rounded, tapered, or beveled to facilitate the passage of the first tissue engaging member 140 and/or the second tissue engaging member 142 through a patient's tissues.
[0057] Referring again to FIG. 5, in one embodiment, as shov~m, the first fixed end 154 of the first interconnecting member 144 is connected to the first tissue engaging member 140 at a point located between the first end 146 and the second end 148 of the first tissue engaging member 140, rather than at one of the opposing ends 146, 148 of the first tissue engaging member 140.
Accordingly, in such an embodiment, the first fixed end 154 of the first intereconnecting member 144 is connected to the intermediate portion 147 of the first tissue engaging member 140 and the opposing ends 146, 148 of the first tissue engaging member 140 are both free ends. .
Alternatively, in another embodiment, the first fixed end 154 of the first interconnecting member 144 is comiected to the first tissue engaging member 140 either at the first end 146 or at the second end 148 of the first tissue engaging member 140. Accordingly, in such an embodiment, one of the first end 146 and the second end 148 of the first tissue engaging member 140 is a fixed end. In a similar fashion, the second fixed end 156 of the first interconnecting member 144 may be connected to the second tissue engaging member 142 at a point located between the first end 150 and the second end 152 of the second tissue engaging member 142 (i.
e., the first interconnecting member 144 may be connected to the intermediate portion 151 of the second tissue engaging member 142), or, alternatively, at one of the opposing ends 150, 152 of the second tissue engaging member 142.
[005] In one embodiment, the first interconnecting member 144 is connected at its first fixed end 154 to the first tissue engaging member 140 and at its second fixed end 156 to the second tissue engaging member 142 by, for example, an adhesive, such as a glue.
Alternatively, the first interconnecting member 144 includes a first hinge 158 at its first fixed end 154 and a second hinge 160 at its second fixed end 156. In one such embodiment, the first hinge 158 connects the first interconnecting member 144 to the first tissue engaging member 140 and the second hinge 160 connects the first interconnecting member 144 to the second tissue engaging member 142.
to In one embodiment, the first lunge 158 and the second hinge 160 allow for rotational movement of the first tissue engaging member 140 and the second tissue engaging member 142, respectively, relative to each other and relative to the first interconnecting member 144.
[0059] In one embodiment, the suturing device 108 is pre-assembled (e.g., manufactured) so that the first interconnecting member 144 continuously connects the first tissue engaging member 140 to the second tissue engaging member 142. In other words, the physician need not, at any point during his or her use of the suturing system 100, connect one portion of the first interconnecting member 144 to another portion of the first interconnecting member 144, or connect either one of the two tissue engaging members 140, 142 to the first intercomlecting member 144. Rather, the suturing device 108 is insertable into a patient in its connected 2o configuration, illustrated in, and described with respect to, for example, FIG. 5.
[0060] In one embodiment, the first interconnecting member 144 is made from a flexible yet resilient material, allowing the first interconnecting member 144 to alternate between a deformed position (e.g., a bent position), as illustrated in FIGS. 2 and 6, and an unstressed position, such as the straight configuration illustrated in FIG. 5. In one embodiment, the first interconnecting member 144 alternates between the deformed and unstressed positions through the application .. _.. - 16 -and removal of, respectively, a force. Referring to FIG. 5, in the unstressed position of the first interconnecting member 144, a longitudinal axis of the first tissue engaging member 140 and a longitudianal axis of the second tissue engaging member 142 are, in one embodiment, each substantially perpendicular to a longitudinal axis of the first interconnecting member 144. With reference to FIGS. 2 and 6, in the deformed position of the first interconnecting member 144, a longitudinal axis of the first tissue engaging member 140 and a longitudinal axis of the second tissue engaging member 142 are, in one embodiment, each substantially parallel to the longitudinal axis of the first interconnecting member 144.
[0061] Referring to FIG. 2, in operation, in one embodiment, the suturing device 108 is initially to positioned within the lumen 130 of the elongate member 104 with its first interconnecting member 144 in the deformed position. Moreover, in one embodiment, the wall 128 of the elongate member 104 constrains the first interconnecting member 144 of the suturing device 108 in the deformed position while the suturing device 108 is located within the lumen 130 of the elongate member 104. Once the suturing device 108 is advanced distally to exit through the 15 opening 132 at the distal end 126 of the elongate member 104, the resiliency of the first interconnecting member 144 causes, in one embodiment, the first interconnecting member 144 of the suturing device 108 to regain its unstressed position, illustrated in FIG. 5.
[0062] Exemplary resilient materials from which the first interconnecting member 144 can be manufactured include bioabsorbable materials such as, but not exclusively, polylactic acid 20 (PLA), polyethylene glycol (PEG), polycaprolactone (PCL), polyglycolic acid (PGA), or magnesium, non-resorbable materials such as, but not exclusively, a metal (e.g., nitinol) or a polymer (e.g., urethane), and/or rubber.
[0063] In some embodiments of the invention, the first interconnecting member 144 of the suturing device 108 possesses elastic properties. For example, in one embodiment, the first 25 interconnecting member 144 can be stretched, and thereafter returned to its original state when the stretching force is removed. More particularly, in one embodiment, as the first interconnecting member 144 is stretched, moving the first tissue engaging member 140 away from the second tissue engaging member 142, a restoring force is generated in the first interconnecting member 144. The restoring force acts to pull the first tissue engaging member 140 back towards the second tissue engaging member 142 when the stretching force is removed.
Exemplary elastic materials from which the first interconnecting member 144 can be manufactured include bioabsorbable materials such as, but not exclusively, polylactic acid (PLA), polyethylene glycol (PEG), polycaprolactone (PCL), or polyglycolic acid (PGA), non-resorbable materials such as, but not exclusively, a polymer or a polymer blend (e.g., urethane), l0 and/or rubber.
[0064] Referring now to FIG. 5, in one embodiment, the first tissue engaging member 140 and/or the second tissue engaging member 142 are substantially cylindrical.
Alternatively, the first tissue engaging member 140 and the second tissue engaging member 142 may have other shapes (e.g., a rectangular prism). In another embodiment, one or both of the first tissue engaging member 140 and the second tissue engaging member 142 has/have an atraumatic structure, i.e., is/are devoid of any outward projections or protrusions that might cause injury or trauma to a patient's tissue. There is, therefore, no impediment to contacting a patient's tissue directly and intimately with the first tissue engaging member 140 and/or the second tissue engaging member 142. For example, in one embodiment where the tissue engaging members 140, 142 are atraumatic, one or both of the opposing ends 146, 148 of the first tissue engaging member 140 and/or one or both of the opposing ends 150, 152 of the second tissue engaging member 142 are rounded.
[0065] In one embodiment, the first interconnecting member 144 has a length of between about 1.0 mm and about 20.0 rrun and a cross-sectional diameter between about 0.01 mm and about 2.0 nun. In another embodiment, a tissue engaging member, for example the first tissue engaging .. .. -1g-member 140, has a length 162 from about 1.0 mm to about 20.0 mm and a cross-sectional diameter 164 from about 0.05 mm to about 5.0 mm.
[0066] FIG. 7 depicts the suturing device 108 according to another illustrative embodiment of the invention. According to the illustrative embodiment, the suturing device 108 also includes one or more third tissue engaging members 168. For example, the suturing device 108 includes two third tissue engaging members 168a, 168b, one of which is connected to the first fixed end 154 of the first interconnecting member 144 and another of which is connected to the second fixed end 156 of the first interconnecting member 144. In one embodiment, a midpoint 170 along the longitudinal axis of the first tissue engaging member 140 is connected to a midpoint io 172 along the longitudinal axis of a third tissue engaging member 168a. In one embodiment, the first tissue engaging member 140 and that third tissue engaging member 168a are delivered, through the lumen 130 of the elongate member 104, co-axially. Upon exiting the opening 132 at the distal end 126 of the elongate member 104, the first tissue engaging member 140 and that third tissue engaging member 168a rotate, for example, relative to one another such that, in one embodiment, the longitudinal axis of the first tissue engaging member 140 is oriented substantially perpendicular to the longitudinal axis of that third tissue engaging member 168a, thereby forming a cross or an X-shape. Similarly, a midpoint 174 along the longitudinal axis of the second tissue engaging member 142 may be connected to a midpoint 176 along the longitudinal axis of another third tissue engaging member 168b. In one embodiment, the second 2o tissue engaging member 142 and that third tissue engaging member 168b axe delivered, through the lumen 130 of the elongate member 104, co-axially. Upon exiting the opening 132 at the distal end 126 of the elongate member 104, the second tissue engaging member 142 and that third tissue engaging member 168b rotate, for example, relative to one another such that, in one embodiment, the longitudinal axis of the second tissue engaging member 142 is oriented substantially perpendicular to the longitudinal axis of that third tissue engaging member 168b, thereby forming a cross or an X-shape. Alternatively, in other embodiments, when the suturing device 108 exits the opening 132 at the distal end 126 of the elongate member 104, the longitudinal axis of the first tissue engaging member 140 and the longitudinal axis of the second tissue engaging member 142 are each oriented at an angle between 0 degrees and 180 degrees relative to the longitudinal axis of their respective third tissue engaging member 168a, 168b.
[0067] FIG. 8 depicts the suturing device 108 according to yet another illustrative embodiment of the invention. According to the illustrative embodiment, the suturing device 108 further includes one or more second interconnecting members 178. For example, in one embodiment, the suturing device 108 includes a chain of second interconnecting members 178. In one such to embodiment, at least one of the second intercomiecting members 178 is connected to either the first tissue engaging member 140 or the second tissue engaging member 142. For example, as illustrated in FIG. 8, a second interconnecting member 178A is connected to the second tissue engaging member 142. Moreover, each one of the second interconnecting members 178 in the chain may be separated from an adjacent second interconnecting member 178 by a third tissue engaging member 168. For example, as illustrated in FIG. 8, a second interconnecting member 178A is separated from an adjacent second interconnecting member 178B by a third tissue engaging member 168A. Accordingly, the suturing device 108 of the invention may consist of a series of alternating tissue engaging members and interconnecting members. Any number of alternating tissue engaging members and interconnecting members may be connected in series to form the chain. Moreover, in general, the second interconnecting members 178 may include some or all of the properties of the first interconnecting member 144 described above, including, for example, the resiliency of the first interconnecting member 144.
Accordingly, the second interconnecting members 178 may also alternate between a deformed position and an unstressed position.
[0068] FIG. 9 depicts the suturing device 108 according to still another illustrative embodiment of the invention. According to the illustrative embodiment, two or more interconnecting members may connect adjacent tissue engaging members. For example, both the first interconnecting member 144 and a second interconnecting member 178E may connect the first tissue engaging member 140 to the second tissue engaging member 142.
Similarly, as another example, three second interconnecting members 178B, 178F, 1786 may connect two adjacent third tissue engaging members 168A, 168B.
[0069] FIG. 10 depicts a suturing device 108' according to another illustrative embodiment of the invention. The exemplary suturing device 108' includes a first interconnecting member 144', a first tissue engaging member 140', and a second tissue engaging member 142' similar to those described above. In one embodiment, the suturing device 108' additionally includes a tightening mechanism 180 connected to the first intercomiecting member 144'. The first interconnecting member 144' may be, for example, a thread. Following implantation of the suturing device 108' in the patient's tissues, the tightening mechanism 180 may be used to remove a slack in the first interconnecting member 144' between the first tissue engaging member 140' and the second tissue engaging member 142'. In one embodiment, for example, the tightening mechanism 180 is a ratchet. Alternatively, in other embodiments, the tightening mechanism 180 is a wire-tie, a slip-knot, or a screw mechanism.
[0070] In one embodiment, referring still to FIG. 10, the first tissue engaging member 140' and/or the second tissue engaging member 142' includes an anchor 182, such as, for example, a spiral tissue anchor 179. Accordingly, the first tissue engaging member 140' and/or the second tissue engaging member 142' may be screwed into a patient's tissues.
Alternatively, in another embodiment, the first tissue engaging member 140' and/or the second tissue engaging member 142' includes a differently shaped anchor 182 for implanting the tissue engaging member 140', 142' into the patient's tissue. For example, the first tissue engaging member 140' and/or the second tissue engaging member 142' may include a barbed tissue anchor 181, as illustrated in FIG. 11. Accordingly, the barbed tissue anchor 181 of the first tissue engaging member 140' and/or the second tissue engaging member 142' may be pushed into a patient's tissues to secure the engaging member 140', 142' in the patient's tissues.
[0071] Some or all of the tissue engaging members 140, 140', 142, 142', 168, the interconnecting members 144, 144', 178, and the tightening mechanism 180 may be manufactured from a bioabsorbable material that, following placement in the patient's body, biodegrades over time and is absorbed into the patient's body, such as, for example, polylactic acid (PLA), polyethylene glycol (PEG), polycaprolactone (PCL), polyglycolic acid (PGA), or to magnesium. In other embodiments, some or all of the tissue engaging members 140, 140', 142, 142', 168, the interconnecting members 144, 144', 178, and the tightening mechanism 180 may be manufactured from a biological material (e.g., an extracellular matrix material) that allows for tissue ingrowth when the suturing device 108, 108' is implanted within a patient's tissues. In yet other'embodiments, some or all of the tissue engaging members 140, 140', 142, 142', 168, the interconnecting members 144, 144', 178, and the tightening mechanism 180 are coated andlor impregnated with a material (e.g.'; a reactive material) for stimulating tissue growth. In one embodiment, the growth stimulating material is collagen. In another embodiment, the growth stimulating material is a growth factor, such as a vascular endothelial growth factor, a basic fibro growth factor, or an angiogenic growth factor. In yet another embodiment, the growth 2o stimulating material is a pharmacological agent for stimulating tissue growth, such as, for example, cells or genes. Alternatively, in still another embodiment, the growth stimulating material is an irritant for encouraging an inflammatory response, such as, for example, cotton seed oil or alcohol.
[0072] Materials that are not bio-absorbable could, alternatively, be used to manufacture different parts of the suturing device 108, 108'. The tissue engaging members 140, 140', 142, 142', 168 andlor the tightening mechanism 180 could, for example, be manufactured using a polymer material, (e.g., polyethylene, nylon, polypropylene, polyester, or polyurethane), a shape memory material, or a metal. For their part, the interconnecting members 144, 144', 178 could, for example, be manufactured using a polymer material, (e.g., polyethylene or polyurethane), a shape memory material, a metal, a thread, a spring, or an elastomer. For example, the tissue engaging members 140, 140', 142, 142', 168, arid the interconnecting members 144, 144', 178 could be manufactured using a nickel-titanium alloy, such as Nitinol. As another example, the tissue engaging members 140, 140', 142, 142', 168, and the interconnecting members 144, 144', 178 can be manufactured as am integral unit by, for example, molding or stamping them from a l0 single piece of material, such as a polymer.
[0073] In yet another embodiment, some or all of the tissue engaging members 140, 140', 142, 142', 168, the interconnecting members 144, 144', 178, and the tightening mechanism 180 are coated with a material that reduces thrombosis, such as, for example, heparin.
In still another embodiment, some or all of the tissue engaging members 140, 140', 142, 142', 168, the interconnecting members 144, 144', 178, and the tightening mechanism 180 include a radiopaque material.
[0074] In another aspect, the invention provides a method for suturing tissue.
FIGS. 12A-12D
illustrate one embodiment of a method for percutaneously suturing closed a patent foramen ovale 52 in the intraatrial septum in the heart of a patient in accordance with the invention. Referring 2o first to FIG. 12A, the physician positions a distal end 183 of a tissue suturing system, such as the tissue suturing system 100 of FIG. 2, within the right atrium 56 of the patient in proximity to the septum secundum 62.
[0075] Optionally, as illustrated in FIG. 12A, the physician also employs a tissue stabilization device 184 with the tissue suturing system 100. In one such embodiment, the tissue stabilization device 184 is connected to a catheter 185. The catheter 185 includes a proximal end (not ._ - 23 -shown), a distal end 187, a lumen 189 that extends from the proximal end to the distal end 187, and an opening 191 that is positioned at the distal end 187 of the catheter 185 and that is in fluid communication with the lumen 189 of the catheter 185. In one embodiment, as illustrated, the catheter 185 is positioned within the lumen 120 of the sheath 102. The elongate member 104, the delivery member 106, and the suturing device 108 are positioned within the lumen 189 of the catheter 185.
[0076] In one embodiment, the physician positions the tissue stabilization device 184 within and through the patent foramen ovate 52 between the septum secundmn 62 and the septum primum 60 of the patient's heart. The tissue stabilization device 184 is used by the physician to, for l0 example, limit movement of the septum secundum 62 and the septum primum 60 prior to forming, as explained below, holes through the septum secundum 62 and the septum primum 60 with the cutting member 134 of the elongate member 104. The tissue stabilization device 184 also serves to position the distal end 187 of the catheter 185 in the area where the septum secundum 62 and the septum primum 60 overlap. Accordingly, when the elongate member 104 15 is extended to exit through the opening 191 at the distal end 187 of the catheter 185, the cutting member 134 of the elongate member 104 pierces holes through the septum secundum 62 and the septum primum 60 in the area where they overlap. In accordance with the method further described below, the suturing device 108 is thereby placed through the septa 60, 62 in the area where they overlap.
2o [0077] Exemplary tissue stabilization devices and flexible members suitable for stabilizing cardiac tissues in a patient and for placing the elements described above in the area where the septum secundum 62 and the septum primum 60 overlap include those described in United States .
patent application Serial No. 10/660,444, the disclosure of which is hereby incorporated herein by reference in its entirety. For example, the tissue stabilization device 184 may: i) be a flexible 25 coil having a spiral shape, illustrated in FIG. 12A, ii) include three flexible hexagonal members forming, generally, a planar array, iii) include two flexible members, each one of which includes a leg, such as a wire, that is pre-shaped to articulate one or more times upon exit from a lumen, iv) include two flexible members, each one of which includes a loop section, or v) be a single flexible member that forms a closed loop.
[0078] Alternatively, in another embodiment, the physician does not employ the tissue stabilization device 184 in suturing the patent foramen ovate 52. Accordingly, while FIGS.
12B-12D do not, for the purposes of simplifying and clarifying the drawings, illustrate the tissue stabilization device 184, it is understood that the tissue stabilization device may or may not be present in practice.
[0079] Referring now to FIG. 12B, the physician extends, in one embodiment, the elongate member 104 distally, so that the cutting member 134 of the elongate member 104 contacts a tissue surface 186 of the septum secundum 62 at a point where the septum secundum 62 overlaps the septum primum 60. By continuing to advance the elongate member 104, the physician forms a first hole 188 in the septum secundum 62 and, subsequently, a second hole 190 in the overlapping septum primum 60.
[0080] Referring now to FIG. 12C, with the distal end 126 of the elongate member 104 in the left atrium 58, the delivery member 106 is advanced toward the distal end 126 of the elongate member 104 until the first tissue engaging member 140 exits the opening 132 at the distal end 126 of the elongate member 104. Once the first tissue engaging member 140 exits the opening , 132, the resiliency of the first interconnecting member 144 causes the first fixed end 154 of the first interconnecting member 144 to return to an unstressed (e.g., a straight) position, such that the longitudinal axis of the first tissue engaging member 140 is substantially perpendicular to the longitudinal axis of the first interconnecting member 144.
[0081] RefeiTing now to FIG. 12D, the physician then retracts the elongate member 104 proximally back through the second hole 190 and the first hole 188, such that the first tissue engaging member 140 is located adjacent a surface 192 of the septum primum 60.
The physician continues to retract the elongate member 104 until the distal end 126 of the elongate member 104 is positioned in the right atrium 56. The delivery member 106 is then further advanced distally until the second tissue engaging member 142 exits the opening 132 at the distal end 126 of the elongate member 104. Once the second tissue engaging member 142 exits the opening 132, the resiliency of the first interconnecting member 144 causes the second fixed end 156 of the first interconnecting member 144 to return to an unstressed (e.g., a straight) position, such that the longitudinal axis of the second tissue engaging member 142 is substantially perpendicular to the longitudinal axis of the first interconnecting member 144. The second tissue engaging member l0 142 is thereby positioned adjacent a tissue surface 186 of the septum secundum 62. Configured as such, the suturing device 108 holds the septum primum 60 and the septum secundum 62 between the first tissue engaging member 140 and the second tissue engaging member 142.
[0082] FIG. 13 depicts a suturing device 108 implanted into the intraatrial septum in the heart of a patient in accordance with another embodiment of the invention. According to the illustrative 15 embodiment, rather than creating the first hole 188 through the septum secundum 62 and the second hole 190 through the septum primum 60 at a point where the septum secundum 62 and the septum primum 60 overlap, as described above, the physician creates the holes 188, 190 at a point where the septum secundum 62 and the septum primum 60 do not overlap.
For example, the physician uses the cutting member 134 to create the first hole 188 through the septum 2o secundum 62, positions the first tissue engaging member 140 in the left atrium 58 adjacent a tissue surface of the septum secundum 62, proximally withdraws the elongate member 104 back into the right atrium 56, uses the cutting member 134 to create the second hole 190 through the septum primum 60, positions the second tissue engaging member 142 in the left atrium 58 adjacent a tissue surface of the septum primum 60, and proximally withdraws the elongate 25 member 104 back into the right atrium 56 for eventual removal from the patient's body. The ._ ...... .. _ - 26 -suturing device 108 thus captures the septum primum 60 and the septum secundum 62 as illustrated in FIG. 13, without occupying a position in the tunnel of the patent foramen ovate 52.
Alternatively, in another embodiment, the physician creates the holes 188, 190 in the septum secundum 62 and the septum primum 60 in the opposite order.
[0083] FIG. 14 depicts a suturing device 108' implanted into the intraatrial septum in the heart of a patient in accordance with another embodiment of the invention. According to the illustrative embodiment, rather than forming holes 188, 190 through the septum secundum 62 and the septum primum 60 to access the left atrium 58, the physician advances the spiral tissue anchors 179 (or the barbed tissue anchors 181) of the tissue engaging members 140', 142' into to the right atrial wall of the septum primum 60 and the septum secundum 62.
In one such embodiment, the distal end 126 of the elongate member 104 is adapted to engage the tissue engaging members 140', 142' as they are advanced by the delivery member 106 to the distal end 126 of the elongate member 104. Once a tissue engaging member 140', 142' is engaged by the distal end 126 of the elongate member 104, the physician then rotates the elongate member 104 to screw the spiral tissue anchor 179 of the tissue engaging member 140', 142' into the patient's tissue, or, alternatively, the physician advances the elongate member 104 to push the barbed tissue anchor 181 of the tissue engaging member 140', 142' into the patient's tissue.
Accordingly, the suturing device 108' captures the septum primum 60 and the septum secundum 62 as illustrated in FIG. 14. Optionally, the physician may then use the tightening mechanism 180 to remove any slack in the first interconnecting member 144' between the first tissue engaging member 140' and the second tissue engaging member 142'.
[0084] In other embodiments, to deliver a suturing device 108, 108' that includes a series of alternating tissue engaging members and interconnecting members, as illustrated in FIGS. 8 and 9, the physician repeats the steps described above with reference to either FIGS. 12A-12D, FIG.
13, or FIG. 14. In some such embodiments, to distally advance the suturing device 108, 108' through the lumen 130 of the elongate member 104, the delivery member 106 abuts the distal most tissue engaging member (e.g., the third tissue engaging member 168D in FIGS. 8 and 9) in the series of alternating tissue engaging members and interconnecting members.
[0085] It should be understood that the order of the steps in the above described methods and/or the order for performing certain actions is immaterial so long as the invention remains operable.
Moreover, two or more steps or actions may be conducted simultaneously.
[0086] Certain embodiments of the present invention were described above. It is, however, expressly noted that the present invention is not limited to those embodiments, but rather the intention is that additions and modifications to what was expressly described herein are also included within the scope of the invention. Moreover, it is to be understood that the features of the various embodiments described herein were not mutually exclusive and can exist in various combinations and permutations, even if such combinations or permutations were not made express herein, without departing from the spirit and scope of the invention.
In fact, variations, modifications, and other implementations of what was described herein will occur to those of ordinaxy skill in the art without departing from the spirit and the scope of the invention. As such, the invention is not to be defined only by the preceding illustrative description.
[0087] What is claimed is:
Claims (28)
1. A suturing system, comprising:
a suturing device, comprising:
a first tissue engaging member comprising a first end, a second end, and a first intermediate portion positioned between the first end and the second end;
a second tissue engaging member comprising a third end, a fourth end, and a second intermediate portion positioned between the third end and the fourth end; and a first interconnecting member comprising a first fixed end connected to the first intermediate portion of the first tissue engaging member, and a second fixed end connected to the second tissue engaging member, wherein the suturing device is insertable into a patient in a connected configuration.
a suturing device, comprising:
a first tissue engaging member comprising a first end, a second end, and a first intermediate portion positioned between the first end and the second end;
a second tissue engaging member comprising a third end, a fourth end, and a second intermediate portion positioned between the third end and the fourth end; and a first interconnecting member comprising a first fixed end connected to the first intermediate portion of the first tissue engaging member, and a second fixed end connected to the second tissue engaging member, wherein the suturing device is insertable into a patient in a connected configuration.
2. The suturing system of claim 1, wherein the second fixed end of the first interconnecting member is connected to the second intermediate portion of the second tissue engaging member.
3. The suturing system of claim 1, wherein the suturing device further comprises a second interconnecting member connected to at least one of the first and second tissue engaging members.
4. The suturing system of claim 3, wherein the suturing device further comprises a third tissue engaging member connected to the second interconnecting member.
5. The suturing system of claim 1, wherein the suturing device further comprises a third tissue engaging member connected to at least one of the first fixed end and the second fixed end of the first interconnecting member.
6. The suturing system of claim 1 further comprising an elongate member comprising a proximal end, a distal end, a wall extending from the proximal end to the distal end, and a cutting member positioned at the distal end, the wall defining a lumen extending from the proximal end to the distal end of the elongate member, and the wall defining an opening at the distal end of the elongate member, wherein the suturing device is disposed within the lumen of the elongate member.
7. The suturing system of claim 6, wherein the elongate member further comprises a retractable gate member positioned at the distal end of the elongate member.
8. The suturing system of claim 6 further comprising a delivery member disposed within the lumen of the elongate member.
9. The suturing system of claim 8, wherein the delivery member is releasably connected to the suturing device.
10. The suturing system of claim 1, wherein the first tissue engaging member further comprises a first lumen extending from the first end to the second end of the first tissue engaging member, and wherein the second tissue engaging member further comprises a second lumen extending from the third end to the fourth end of the second tissue engaging member.
11. The suturing system of claim 10 further comprising an elongate member comprising a proximal end, a distal end, a wall extending from the proximal end to the distal end, and a cutting member positioned at the distal end, wherein the elongate member is disposed within the first lumen of the first tissue engaging member and within the second lumen of the second tissue engaging member.
12. The suturing system of claim 1, wherein at least one of the first and second tissue engaging members is substantially cylindrical.
13. The suturing system of claim 1, wherein at least one end of at least one of the first and second tissue engaging members is rounded.
14. The suturing system of claim 1, wherein the first interconnecting member is reciprocally moveable between an unstressed position and a deformed position.
15. The suturing system of claim 1, wherein the first interconnecting member comprises a stretchable material.
16. The suturing system of claim 1, wherein at least one of the first and second tissue engaging members and the first interconnecting member comprises a material for stimulating tissue growth.
17. The suturing system of claim 16, wherein the material for stimulating tissue growth comprises collagen.
18. The suturing system of claim 1, wherein at least one of the first and second tissue engaging members and the first interconnecting member comprises a bioabsorbable material.
19. The suturing system of claim 18, wherein the bioabsorbable material comprises polylactic acid.
20. A suturing device, comprising:
a first tissue engaging member;
a second tissue engaging member;
a first interconnecting member connecting the first tissue engaging member to the second tissue engaging member; and a first anchor connected to the first tissue engaging member.
a first tissue engaging member;
a second tissue engaging member;
a first interconnecting member connecting the first tissue engaging member to the second tissue engaging member; and a first anchor connected to the first tissue engaging member.
21. The suturing device of claim 20 further comprising a second anchor connected to the second tissue engaging member.
22. The suturing device of claim 21, wherein at least one of the first anchor and the second anchor is a spiral tissue anchor.
23. The suturing device of claim 21, wherein at least one of the first anchor and the second anchor is a barbed tissue anchor.
24. A method for suturing tissue, comprising:
inserting a suturing device into a heart of a patient, the suturing device comprising:
a first tissue engaging member comprising a first end, a second end, and a first intermediate portion positioned between the first end and the second end;
a second tissue engaging member comprising a third end, a fourth end, and a second intermediate portion positioned between the third end and the fourth end;
and a first interconnecting member comprising a first fixed end connected to the first intermediate portion of the first tissue engaging member, and a second fixed end connected to the second tissue engaging member, wherein the suturing device is insertable into a patient in a connected configuration, and attaching the suturing device to at least one tissue surface in the heart of the patient.
inserting a suturing device into a heart of a patient, the suturing device comprising:
a first tissue engaging member comprising a first end, a second end, and a first intermediate portion positioned between the first end and the second end;
a second tissue engaging member comprising a third end, a fourth end, and a second intermediate portion positioned between the third end and the fourth end;
and a first interconnecting member comprising a first fixed end connected to the first intermediate portion of the first tissue engaging member, and a second fixed end connected to the second tissue engaging member, wherein the suturing device is insertable into a patient in a connected configuration, and attaching the suturing device to at least one tissue surface in the heart of the patient.
25. The method for suturing tissue of claim 24, wherein attaching the suturing device comprises extending the first tissue engaging member through a first hole in a first tissue layer and through a second hole in a second tissue layer, positioning the first tissue engaging member on a tissue surface of the second tissue layer, and positioning the second tissue engaging member on a tissue surface of the first tissue layer.
26. The method for suturing tissue of claim 24, wherein attaching the suturing device comprises extending the first tissue engaging member through a first hole in a first tissue layer, positioning the first tissue engaging member on a tissue surface of the first tissue layer, extending the second tissue engaging member through a second hole in a second tissue layer, and positioning the second tissue engaging member on a tissue surface of the second tissue layer.
27. The method for suturing tissue of claim 24, wherein the at least one tissue surface in the heart of the patient comprises a tissue surface of a septum primum and a tissue surface of a septum secundum.
28. The method for suturing tissue of claim 27 further comprising positioning a tissue stabilization device in a patent foramen ovale.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50194803P | 2003-09-11 | 2003-09-11 | |
US60/501,948 | 2003-09-11 | ||
PCT/US2004/012913 WO2005034763A1 (en) | 2003-09-11 | 2004-04-27 | Devices, systems, and methods for suturing tissue |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2538476A1 true CA2538476A1 (en) | 2005-04-21 |
Family
ID=34434834
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002538476A Abandoned CA2538476A1 (en) | 2003-09-11 | 2004-04-27 | Devices, systems, and methods for suturing tissue |
Country Status (5)
Country | Link |
---|---|
US (1) | US7691112B2 (en) |
EP (1) | EP1663011A1 (en) |
JP (1) | JP2007504885A (en) |
CA (1) | CA2538476A1 (en) |
WO (1) | WO2005034763A1 (en) |
Families Citing this family (155)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8795332B2 (en) | 2002-09-30 | 2014-08-05 | Ethicon, Inc. | Barbed sutures |
US6241747B1 (en) | 1993-05-03 | 2001-06-05 | Quill Medical, Inc. | Barbed Bodily tissue connector |
US5931855A (en) | 1997-05-21 | 1999-08-03 | Frank Hoffman | Surgical methods using one-way suture |
US7662161B2 (en) | 1999-09-13 | 2010-02-16 | Rex Medical, L.P | Vascular hole closure device |
US6440152B1 (en) * | 2000-07-28 | 2002-08-27 | Microvena Corporation | Defect occluder release assembly and method |
US7056331B2 (en) | 2001-06-29 | 2006-06-06 | Quill Medical, Inc. | Suture method |
US7288105B2 (en) * | 2001-08-01 | 2007-10-30 | Ev3 Endovascular, Inc. | Tissue opening occluder |
US6848152B2 (en) | 2001-08-31 | 2005-02-01 | Quill Medical, Inc. | Method of forming barbs on a suture and apparatus for performing same |
US20050267495A1 (en) * | 2004-05-17 | 2005-12-01 | Gateway Medical, Inc. | Systems and methods for closing internal tissue defects |
US6702835B2 (en) | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US20060052821A1 (en) * | 2001-09-06 | 2006-03-09 | Ovalis, Inc. | Systems and methods for treating septal defects |
US6776784B2 (en) | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
US20080015633A1 (en) * | 2001-09-06 | 2008-01-17 | Ryan Abbott | Systems and Methods for Treating Septal Defects |
US20090054912A1 (en) * | 2001-09-06 | 2009-02-26 | Heanue Taylor A | Systems and Methods for Treating Septal Defects |
US6773450B2 (en) | 2002-08-09 | 2004-08-10 | Quill Medical, Inc. | Suture anchor and method |
US20040092973A1 (en) * | 2002-09-23 | 2004-05-13 | Nmt Medical, Inc. | Septal puncture device |
US8100940B2 (en) | 2002-09-30 | 2012-01-24 | Quill Medical, Inc. | Barb configurations for barbed sutures |
US20040088003A1 (en) * | 2002-09-30 | 2004-05-06 | Leung Jeffrey C. | Barbed suture in combination with surgical needle |
WO2004069055A2 (en) * | 2003-02-04 | 2004-08-19 | Ev3 Sunnyvale Inc. | Patent foramen ovale closure system |
US7624487B2 (en) | 2003-05-13 | 2009-12-01 | Quill Medical, Inc. | Apparatus and method for forming barbs on a suture |
ES2293357T3 (en) * | 2003-10-24 | 2008-03-16 | Ev3 Endovascular, Inc. | CLOSURE SYSTEM OF A PERMEABLE OVAL FORM. |
US7666203B2 (en) * | 2003-11-06 | 2010-02-23 | Nmt Medical, Inc. | Transseptal puncture apparatus |
US8292910B2 (en) | 2003-11-06 | 2012-10-23 | Pressure Products Medical Supplies, Inc. | Transseptal puncture apparatus |
US20050187568A1 (en) * | 2004-02-20 | 2005-08-25 | Klenk Alan R. | Devices and methods for closing a patent foramen ovale with a coil-shaped closure device |
EP2664282B1 (en) | 2004-05-14 | 2017-06-21 | Ethicon, LLC | Suture devices |
US8088130B2 (en) | 2006-02-03 | 2012-01-03 | Biomet Sports Medicine, Llc | Method and apparatus for coupling soft tissue to a bone |
US7905904B2 (en) * | 2006-02-03 | 2011-03-15 | Biomet Sports Medicine, Llc | Soft tissue repair device and associated methods |
US8303604B2 (en) | 2004-11-05 | 2012-11-06 | Biomet Sports Medicine, Llc | Soft tissue repair device and method |
US7909851B2 (en) | 2006-02-03 | 2011-03-22 | Biomet Sports Medicine, Llc | Soft tissue repair device and associated methods |
US9017381B2 (en) | 2007-04-10 | 2015-04-28 | Biomet Sports Medicine, Llc | Adjustable knotless loops |
US9801708B2 (en) | 2004-11-05 | 2017-10-31 | Biomet Sports Medicine, Llc | Method and apparatus for coupling soft tissue to a bone |
US8298262B2 (en) | 2006-02-03 | 2012-10-30 | Biomet Sports Medicine, Llc | Method for tissue fixation |
US8361113B2 (en) | 2006-02-03 | 2013-01-29 | Biomet Sports Medicine, Llc | Method and apparatus for coupling soft tissue to a bone |
US8137382B2 (en) | 2004-11-05 | 2012-03-20 | Biomet Sports Medicine, Llc | Method and apparatus for coupling anatomical features |
US8128658B2 (en) | 2004-11-05 | 2012-03-06 | Biomet Sports Medicine, Llc | Method and apparatus for coupling soft tissue to bone |
US7749250B2 (en) | 2006-02-03 | 2010-07-06 | Biomet Sports Medicine, Llc | Soft tissue repair assembly and associated method |
US8118836B2 (en) | 2004-11-05 | 2012-02-21 | Biomet Sports Medicine, Llc | Method and apparatus for coupling soft tissue to a bone |
US7658751B2 (en) | 2006-09-29 | 2010-02-09 | Biomet Sports Medicine, Llc | Method for implanting soft tissue |
US8078266B2 (en) | 2005-10-25 | 2011-12-13 | Voyage Medical, Inc. | Flow reduction hood systems |
US11478152B2 (en) | 2005-02-02 | 2022-10-25 | Intuitive Surgical Operations, Inc. | Electrophysiology mapping and visualization system |
US9510732B2 (en) | 2005-10-25 | 2016-12-06 | Intuitive Surgical Operations, Inc. | Methods and apparatus for efficient purging |
US10064540B2 (en) | 2005-02-02 | 2018-09-04 | Intuitive Surgical Operations, Inc. | Visualization apparatus for transseptal access |
US7930016B1 (en) | 2005-02-02 | 2011-04-19 | Voyage Medical, Inc. | Tissue closure system |
US8137333B2 (en) | 2005-10-25 | 2012-03-20 | Voyage Medical, Inc. | Delivery of biological compounds to ischemic and/or infarcted tissue |
US20080015569A1 (en) | 2005-02-02 | 2008-01-17 | Voyage Medical, Inc. | Methods and apparatus for treatment of atrial fibrillation |
EP2135560B1 (en) * | 2005-06-02 | 2011-08-10 | Cordis Corporation | Medical device for deploying a mechanical closure devcie |
EP1909655A2 (en) | 2005-06-20 | 2008-04-16 | Sutura, Inc. | Method and apparatus for applying a knot to a suture |
US8579936B2 (en) | 2005-07-05 | 2013-11-12 | ProMed, Inc. | Centering of delivery devices with respect to a septal defect |
CN101257852B (en) * | 2005-07-07 | 2011-08-10 | 科迪斯公司 | Patent foramen oval closure device with steerable delivery system |
US7998095B2 (en) * | 2005-08-19 | 2011-08-16 | Boston Scientific Scimed, Inc. | Occlusion device |
US8062309B2 (en) * | 2005-08-19 | 2011-11-22 | Boston Scientific Scimed, Inc. | Defect occlusion apparatus, system, and method |
US7837619B2 (en) * | 2005-08-19 | 2010-11-23 | Boston Scientific Scimed, Inc. | Transeptal apparatus, system, and method |
AU2006287211B2 (en) | 2005-09-01 | 2012-09-27 | Cardinal Health 529, Llc | Patent foramen ovale closure method |
US7846179B2 (en) | 2005-09-01 | 2010-12-07 | Ovalis, Inc. | Suture-based systems and methods for treating septal defects |
US7722631B2 (en) * | 2005-09-28 | 2010-05-25 | Olympus Medical Systems Corporation | Method for suturing perforation |
US8221310B2 (en) | 2005-10-25 | 2012-07-17 | Voyage Medical, Inc. | Tissue visualization device and method variations |
US8303627B2 (en) | 2006-01-09 | 2012-11-06 | Cook Medical Technologies Llc | Patent foramen ovale closure device and method |
US10517587B2 (en) | 2006-02-03 | 2019-12-31 | Biomet Sports Medicine, Llc | Method and apparatus for forming a self-locking adjustable loop |
US8597327B2 (en) | 2006-02-03 | 2013-12-03 | Biomet Manufacturing, Llc | Method and apparatus for sternal closure |
US8562645B2 (en) | 2006-09-29 | 2013-10-22 | Biomet Sports Medicine, Llc | Method and apparatus for forming a self-locking adjustable loop |
US9078644B2 (en) | 2006-09-29 | 2015-07-14 | Biomet Sports Medicine, Llc | Fracture fixation device |
US8801783B2 (en) | 2006-09-29 | 2014-08-12 | Biomet Sports Medicine, Llc | Prosthetic ligament system for knee joint |
US11259792B2 (en) | 2006-02-03 | 2022-03-01 | Biomet Sports Medicine, Llc | Method and apparatus for coupling anatomical features |
US8562647B2 (en) | 2006-09-29 | 2013-10-22 | Biomet Sports Medicine, Llc | Method and apparatus for securing soft tissue to bone |
US11311287B2 (en) | 2006-02-03 | 2022-04-26 | Biomet Sports Medicine, Llc | Method for tissue fixation |
US8968364B2 (en) | 2006-02-03 | 2015-03-03 | Biomet Sports Medicine, Llc | Method and apparatus for fixation of an ACL graft |
US9538998B2 (en) | 2006-02-03 | 2017-01-10 | Biomet Sports Medicine, Llc | Method and apparatus for fracture fixation |
US9149267B2 (en) | 2006-02-03 | 2015-10-06 | Biomet Sports Medicine, Llc | Method and apparatus for coupling soft tissue to a bone |
US8652171B2 (en) | 2006-02-03 | 2014-02-18 | Biomet Sports Medicine, Llc | Method and apparatus for soft tissue fixation |
US8652172B2 (en) | 2006-02-03 | 2014-02-18 | Biomet Sports Medicine, Llc | Flexible anchors for tissue fixation |
US9468433B2 (en) | 2006-02-03 | 2016-10-18 | Biomet Sports Medicine, Llc | Method and apparatus for forming a self-locking adjustable loop |
CA2653396C (en) * | 2006-06-09 | 2015-02-17 | Cordis Corporation | Single disc occlusionary patent foramen ovale closure device |
US9055906B2 (en) | 2006-06-14 | 2015-06-16 | Intuitive Surgical Operations, Inc. | In-vivo visualization systems |
US10004388B2 (en) | 2006-09-01 | 2018-06-26 | Intuitive Surgical Operations, Inc. | Coronary sinus cannulation |
WO2008028149A2 (en) | 2006-09-01 | 2008-03-06 | Voyage Medical, Inc. | Electrophysiology mapping and visualization system |
US20080097476A1 (en) | 2006-09-01 | 2008-04-24 | Voyage Medical, Inc. | Precision control systems for tissue visualization and manipulation assemblies |
US8894682B2 (en) * | 2006-09-11 | 2014-11-25 | Boston Scientific Scimed, Inc. | PFO clip |
US7875053B2 (en) | 2006-09-15 | 2011-01-25 | Cardica, Inc. | Apparatus and method for closure of patent foramen ovale |
US9918826B2 (en) | 2006-09-29 | 2018-03-20 | Biomet Sports Medicine, Llc | Scaffold for spring ligament repair |
US11259794B2 (en) | 2006-09-29 | 2022-03-01 | Biomet Sports Medicine, Llc | Method for implanting soft tissue |
US8672969B2 (en) | 2006-09-29 | 2014-03-18 | Biomet Sports Medicine, Llc | Fracture fixation device |
WO2008042868A1 (en) * | 2006-09-29 | 2008-04-10 | Cordis Corporation | Single disc intraluminal fixation patent foramen ovale closure device |
US20080312729A1 (en) * | 2006-10-04 | 2008-12-18 | Michael Laufer | Methods of tissue reconfiguration |
EP2083702B1 (en) | 2006-10-05 | 2019-02-13 | Covidien LP | Axial stitching device |
US8177794B2 (en) | 2006-10-05 | 2012-05-15 | Tyco Healthcare Group Lp | Flexible endoscopic stitching devices |
EP2094167B1 (en) * | 2006-11-30 | 2011-06-29 | Wilson-Cook Medical, Inc. | Visceral anchors for purse-string closure of perforations |
US8758229B2 (en) | 2006-12-21 | 2014-06-24 | Intuitive Surgical Operations, Inc. | Axial visualization systems |
US8915943B2 (en) | 2007-04-13 | 2014-12-23 | Ethicon, Inc. | Self-retaining systems for surgical procedures |
US8657805B2 (en) | 2007-05-08 | 2014-02-25 | Intuitive Surgical Operations, Inc. | Complex shape steerable tissue visualization and manipulation catheter |
US9056155B1 (en) * | 2007-05-29 | 2015-06-16 | Abbott Cardiovascular Systems Inc. | Coatings having an elastic primer layer |
US9101357B2 (en) * | 2007-06-08 | 2015-08-11 | Board Of Trustees Of The University Of Arkansas | Physiologic abdominal closure |
EP2550978B1 (en) | 2007-09-27 | 2014-04-30 | Ethicon, LLC | A system for cutting a retainer in a suture |
US8771314B2 (en) * | 2007-09-28 | 2014-07-08 | Ethicon, Inc. | Surgical anchor device |
US20090118762A1 (en) * | 2007-10-31 | 2009-05-07 | Lawrence Crainch | Disposable cartridge for use in a gastric volume reduction procedure |
US8496684B2 (en) * | 2007-10-31 | 2013-07-30 | Ethicon Endo-Surgery, Inc. | Method for deploying a device for gastric volume reduction |
WO2009086172A2 (en) | 2007-12-19 | 2009-07-09 | Angiotech Pharmaceuticals, Inc. | Self-retaining sutures with heat-contact mediated retainers |
US8916077B1 (en) | 2007-12-19 | 2014-12-23 | Ethicon, Inc. | Self-retaining sutures with retainers formed from molten material |
US8118834B1 (en) | 2007-12-20 | 2012-02-21 | Angiotech Pharmaceuticals, Inc. | Composite self-retaining sutures and method |
US8615856B1 (en) | 2008-01-30 | 2013-12-31 | Ethicon, Inc. | Apparatus and method for forming self-retaining sutures |
US8875607B2 (en) | 2008-01-30 | 2014-11-04 | Ethicon, Inc. | Apparatus and method for forming self-retaining sutures |
US20110029013A1 (en) | 2008-02-15 | 2011-02-03 | Mcguckin James F | Vascular Hole Closure Device |
US8070772B2 (en) | 2008-02-15 | 2011-12-06 | Rex Medical, L.P. | Vascular hole closure device |
US8491629B2 (en) | 2008-02-15 | 2013-07-23 | Rex Medical | Vascular hole closure delivery device |
US9226738B2 (en) * | 2008-02-15 | 2016-01-05 | Rex Medical, L.P. | Vascular hole closure delivery device |
ES2706295T3 (en) | 2008-02-21 | 2019-03-28 | Ethicon Llc | Method and apparatus for raising retainers in self-retaining sutures |
US8216273B1 (en) | 2008-02-25 | 2012-07-10 | Ethicon, Inc. | Self-retainers with supporting structures on a suture |
US8641732B1 (en) | 2008-02-26 | 2014-02-04 | Ethicon, Inc. | Self-retaining suture with variable dimension filament and method |
US8864776B2 (en) * | 2008-04-11 | 2014-10-21 | Covidien Lp | Deployment system for surgical suture |
WO2009129251A2 (en) | 2008-04-15 | 2009-10-22 | Angiotech Pharmaceuticals, Inc. | Self-retaining sutures with bi-directional retainers or uni-directional retainers |
US20110040308A1 (en) | 2008-06-13 | 2011-02-17 | Ramiro Cabrera | Endoscopic Stitching Devices |
US8628545B2 (en) * | 2008-06-13 | 2014-01-14 | Covidien Lp | Endoscopic stitching devices |
EP2352440B1 (en) | 2008-11-03 | 2019-02-20 | Ethicon LLC | Length of self-retaining suture and device for using the same |
CA2745755A1 (en) * | 2008-12-05 | 2010-06-10 | Kenneth Chang | Hood method and device for material dissection |
EP2384149B1 (en) * | 2008-12-05 | 2015-12-02 | Cook Medical Technologies LLC | Tissue anchors for purse-string closure of perforations |
USD698021S1 (en) | 2009-05-12 | 2014-01-21 | Ethicon, Inc. | Surgical fastener |
US8579920B2 (en) | 2009-05-12 | 2013-11-12 | Ethicon, Inc. | Surgical fasteners, applicator instruments, and methods for deploying surgical fasteners |
US8920439B2 (en) | 2009-05-12 | 2014-12-30 | Ethicon, Inc. | Applicator instruments having curved and articulating shafts for deploying surgical fasteners and methods therefor |
US8894669B2 (en) | 2009-05-12 | 2014-11-25 | Ethicon, Inc. | Surgical fasteners, applicator instruments, and methods for deploying surgical fasteners |
US8728098B2 (en) * | 2009-05-12 | 2014-05-20 | Ethicon, Inc. | Surgical fasteners, applicator instruments, and methods for deploying surgical fasteners |
US8728099B2 (en) * | 2009-05-12 | 2014-05-20 | Ethicon, Inc. | Surgical fasteners, applicator instruments, and methods for deploying surgical fasteners |
US9055945B2 (en) | 2009-05-12 | 2015-06-16 | Ethicon, Inc. | Surgical fasteners having articulating joints and deflectable tips |
USD744646S1 (en) | 2009-05-12 | 2015-12-01 | Ethicon, Inc. | Surgical fastener |
USD708746S1 (en) | 2009-06-10 | 2014-07-08 | Covidien Lp | Handle for surgical device |
EP3607888A1 (en) | 2009-09-07 | 2020-02-12 | Aeeg Ab | Device and kit for closure of a body lumen puncture |
US8490713B2 (en) * | 2009-10-06 | 2013-07-23 | Covidien Lp | Handle assembly for endoscopic suturing device |
WO2011090628A2 (en) | 2009-12-29 | 2011-07-28 | Angiotech Pharmaceuticals, Inc. | Bidirectional self-retaining sutures with laser-marked and/or non-laser marked indicia and methods |
US9307980B2 (en) | 2010-01-22 | 2016-04-12 | 4Tech Inc. | Tricuspid valve repair using tension |
US10058323B2 (en) | 2010-01-22 | 2018-08-28 | 4 Tech Inc. | Tricuspid valve repair using tension |
NZ702869A (en) | 2010-05-04 | 2016-05-27 | Ethicon Llc | Self-retaining systems having laser-cut retainers |
CA2801271C (en) | 2010-06-11 | 2018-10-30 | Ethicon, Llc | Suture delivery tools for endoscopic and robot-assisted surgery and methods |
CA2816326C (en) | 2010-11-03 | 2020-12-15 | Ethicon, Llc | Drug-eluting self-retaining sutures and methods relating thereto |
MX342984B (en) | 2010-11-09 | 2016-10-19 | Ethicon Llc | Emergency self-retaining sutures and packaging. |
US8968340B2 (en) | 2011-02-23 | 2015-03-03 | Covidien Lp | Single actuating jaw flexible endolumenal stitching device |
AU2012230716B2 (en) | 2011-03-23 | 2016-05-19 | Ethicon Llc | Self-retaining variable loop sutures |
US20130172931A1 (en) | 2011-06-06 | 2013-07-04 | Jeffrey M. Gross | Methods and devices for soft palate tissue elevation procedures |
CA2850181A1 (en) * | 2011-09-30 | 2013-04-04 | Bioventrix, Inc. | Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditions |
US9357991B2 (en) | 2011-11-03 | 2016-06-07 | Biomet Sports Medicine, Llc | Method and apparatus for stitching tendons |
US9381013B2 (en) | 2011-11-10 | 2016-07-05 | Biomet Sports Medicine, Llc | Method for coupling soft tissue to a bone |
US9314241B2 (en) | 2011-11-10 | 2016-04-19 | Biomet Sports Medicine, Llc | Apparatus for coupling soft tissue to a bone |
US9821145B2 (en) | 2012-03-23 | 2017-11-21 | Pressure Products Medical Supplies Inc. | Transseptal puncture apparatus and method for using the same |
US9788948B2 (en) | 2013-01-09 | 2017-10-17 | 4 Tech Inc. | Soft tissue anchors and implantation techniques |
US9918827B2 (en) | 2013-03-14 | 2018-03-20 | Biomet Sports Medicine, Llc | Scaffold for spring ligament repair |
EP3079602B1 (en) | 2013-12-06 | 2020-01-22 | Med-venture Investments, LLC | Suturing apparatuses |
US9468434B2 (en) | 2014-06-03 | 2016-10-18 | Covidien Lp | Stitching end effector |
EP3157607B1 (en) * | 2014-06-19 | 2019-08-07 | 4Tech Inc. | Cardiac tissue cinching |
US10092286B2 (en) | 2015-05-27 | 2018-10-09 | Covidien Lp | Suturing loading unit |
ITUB20151949A1 (en) * | 2015-07-03 | 2017-01-03 | Paolis Paolo De | Tissue suture device for open or laparoscopic surgical use. |
US10542970B2 (en) | 2016-05-31 | 2020-01-28 | Covidien Lp | Endoscopic stitching device |
EP4115818A3 (en) | 2017-06-19 | 2023-04-05 | Heartstitch, Inc. | Suturing systems and methods for suturing body tissue |
US11591554B2 (en) | 2017-09-11 | 2023-02-28 | Heartstitch, Inc. | Methods and devices for papillary suturing |
US10993807B2 (en) | 2017-11-16 | 2021-05-04 | Medtronic Vascular, Inc. | Systems and methods for percutaneously supporting and manipulating a septal wall |
US11197665B2 (en) | 2018-08-06 | 2021-12-14 | Covidien Lp | Needle reload device for use with endostitch device |
US11504105B2 (en) | 2019-01-25 | 2022-11-22 | Rex Medical L.P. | Vascular hole closure device |
US11766556B2 (en) * | 2019-04-04 | 2023-09-26 | Medtronic, Inc. | Cannula fixation device |
CN113827284B (en) * | 2021-09-15 | 2023-04-14 | 宁波迪创医疗科技有限公司 | Tissue defect's closure apparatus |
Family Cites Families (232)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3077733A (en) | 1959-08-17 | 1963-02-19 | Phillips Petroleum Co | Method of making jet fuel and use thereof |
US3103666A (en) | 1961-12-28 | 1963-09-17 | Dennison Mfg Co | Tag attaching apparatus |
US3470834A (en) | 1968-03-08 | 1969-10-07 | Dennison Mfg Co | Fastener attaching device |
US3716058A (en) | 1970-07-17 | 1973-02-13 | Atlanta Res Inst | Barbed suture |
US3874388A (en) | 1973-02-12 | 1975-04-01 | Ochsner Med Found Alton | Shunt defect closure system |
US3875648A (en) | 1973-04-04 | 1975-04-08 | Dennison Mfg Co | Fastener attachment apparatus and method |
US4039078A (en) | 1973-04-04 | 1977-08-02 | Dennison Manufacturing Company | Fastener attachment stock |
US4006747A (en) * | 1975-04-23 | 1977-02-08 | Ethicon, Inc. | Surgical method |
US4007743A (en) | 1975-10-20 | 1977-02-15 | American Hospital Supply Corporation | Opening mechanism for umbrella-like intravascular shunt defect closure device |
US3990619A (en) | 1975-11-12 | 1976-11-09 | Dennison Manufacturing Company | Fastener attachment needle |
US4235238A (en) | 1978-05-11 | 1980-11-25 | Olympus Optical Co., Ltd. | Apparatus for suturing coeliac tissues |
US4394864A (en) | 1981-04-15 | 1983-07-26 | Jeffrey Sandhaus | Apparatus and method for effecting occlusion of the vas deferens |
US4485816A (en) | 1981-06-25 | 1984-12-04 | Alchemia | Shape-memory surgical staple apparatus and method for use in surgical suturing |
US4425908A (en) | 1981-10-22 | 1984-01-17 | Beth Israel Hospital | Blood clot filter |
US4586502A (en) * | 1982-02-03 | 1986-05-06 | Ethicon, Inc. | Surgical instrument actuator with non-collinear hydraulic pistons |
US5190546A (en) | 1983-10-14 | 1993-03-02 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
US4515583A (en) | 1983-10-17 | 1985-05-07 | Coopervision, Inc. | Operative elliptical probe for ultrasonic surgical instrument and method of its use |
US4556050A (en) | 1984-05-02 | 1985-12-03 | Hodgson Darel E | Artificial sphincter including a shape memory member |
DE3447642C1 (en) | 1984-12-28 | 1986-09-18 | Bernhard M. Dr. 5600 Wuppertal Cramer | Steerable guidewire for catheters |
US4696300A (en) | 1985-04-11 | 1987-09-29 | Dennison Manufacturing Company | Fastener for joining materials |
US4669473A (en) * | 1985-09-06 | 1987-06-02 | Acufex Microsurgical, Inc. | Surgical fastener |
US4705040A (en) * | 1985-11-18 | 1987-11-10 | Medi-Tech, Incorporated | Percutaneous fixation of hollow organs |
WO1988005316A1 (en) | 1987-01-13 | 1988-07-28 | Terumo Kabushiki Kaisha | Balloon catheter and production thereof |
US4844066A (en) | 1987-04-06 | 1989-07-04 | Richard-Allan Medical Industries, Inc. | Surgical clip |
US5478353A (en) | 1987-05-14 | 1995-12-26 | Yoon; Inbae | Suture tie device system and method for suturing anatomical tissue proximate an opening |
US4836204A (en) | 1987-07-06 | 1989-06-06 | Landymore Roderick W | Method for effecting closure of a perforation in the septum of the heart |
US4834096A (en) | 1987-10-26 | 1989-05-30 | Edward Weck Incorporated | Plastic ligating clips |
US4799483A (en) | 1988-02-11 | 1989-01-24 | Kraff Manus C | Suturing needle with tail mounted cutting blade and method for using same |
IT1216042B (en) | 1988-03-09 | 1990-02-22 | Carlo Rebuffat | AUTOMATIC TOOL FOR TOBACCO BAG SUTURES FOR SURGICAL USE. |
FR2641692A1 (en) | 1989-01-17 | 1990-07-20 | Nippon Zeon Co | Plug for closing an opening for a medical application, and device for the closure plug making use thereof |
US5486185A (en) | 1989-01-30 | 1996-01-23 | Dexide, Inc. | Surgical apparatus |
US5073166A (en) | 1989-02-15 | 1991-12-17 | Medical Innovations Corporation | Method and apparatus for emplacement of a gastrostomy catheter |
US5620461A (en) | 1989-05-29 | 1997-04-15 | Muijs Van De Moer; Wouter M. | Sealing device |
US4985014A (en) | 1989-07-11 | 1991-01-15 | Orejola Wilmo C | Ventricular venting loop |
US5030199A (en) | 1989-12-11 | 1991-07-09 | Medical Engineering Corporation | Female incontinence control device with magnetically operable valve and method |
US5049153A (en) | 1989-12-26 | 1991-09-17 | Nakao Naomi L | Endoscopic stapling device and method |
DE69102515T2 (en) | 1990-04-02 | 1994-10-20 | Kanji Inoue | DEVICE FOR CLOSING A SHUTTER OPENING BY MEANS OF A NON-OPERATIONAL METHOD. |
US5021059A (en) | 1990-05-07 | 1991-06-04 | Kensey Nash Corporation | Plug device with pulley for sealing punctures in tissue and methods of use |
US5037433A (en) | 1990-05-17 | 1991-08-06 | Wilk Peter J | Endoscopic suturing device and related method and suture |
US5041129A (en) | 1990-07-02 | 1991-08-20 | Acufex Microsurgical, Inc. | Slotted suture anchor and method of anchoring a suture |
US5057114A (en) | 1990-09-18 | 1991-10-15 | Cook Incorporated | Medical retrieval basket |
CA2093821A1 (en) | 1990-10-09 | 1992-04-10 | Walter R. Pyka | Device or apparatus for manipulating matter |
US5190528A (en) | 1990-10-19 | 1993-03-02 | Boston University | Percutaneous transseptal left atrial cannulation system |
US5372146A (en) | 1990-11-06 | 1994-12-13 | Branch; Thomas P. | Method and apparatus for re-approximating tissue |
US5108420A (en) | 1991-02-01 | 1992-04-28 | Temple University | Aperture occlusion device |
US5112310A (en) | 1991-02-06 | 1992-05-12 | Grobe James L | Apparatus and methods for percutaneous endoscopic gastrostomy |
US5749895A (en) | 1991-02-13 | 1998-05-12 | Fusion Medical Technologies, Inc. | Method for bonding or fusion of biological tissue and material |
US5257637A (en) | 1991-03-22 | 1993-11-02 | El Gazayerli Mohamed M | Method for suture knot placement and tying |
US5584803A (en) | 1991-07-16 | 1996-12-17 | Heartport, Inc. | System for cardiac procedures |
US6730081B1 (en) | 1991-10-18 | 2004-05-04 | Ashvin H. Desai | Endoscopic surgical instrument |
EP0545091B1 (en) | 1991-11-05 | 1999-07-07 | The Children's Medical Center Corporation | Occluder for repair of cardiac and vascular defects |
CA2082090C (en) | 1991-11-05 | 2004-04-27 | Jack Fagan | Improved occluder for repair of cardiac and vascular defects |
US5282827A (en) | 1991-11-08 | 1994-02-01 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
US5222974A (en) | 1991-11-08 | 1993-06-29 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
DE69324239T2 (en) | 1992-01-21 | 1999-11-04 | Univ Minnesota | SEPTUAL DAMAGE CLOSURE DEVICE |
IL100721A (en) | 1992-01-21 | 1996-12-05 | Milo Simcha | Punch for opening passages between two compartments |
US5649950A (en) | 1992-01-22 | 1997-07-22 | C. R. Bard | System for the percutaneous transluminal front-end loading delivery and retrieval of a prosthetic occluder |
US5417700A (en) | 1992-03-30 | 1995-05-23 | Thomas D. Egan | Automatic suturing and ligating device |
US5411481A (en) | 1992-04-08 | 1995-05-02 | American Cyanamid Co. | Surgical purse string suturing instrument and method |
US5236440A (en) | 1992-04-14 | 1993-08-17 | American Cyanamid Company | Surgical fastener |
US5354308A (en) | 1992-05-01 | 1994-10-11 | Beth Israel Hospital Association | Metal wire stent |
US5540712A (en) | 1992-05-01 | 1996-07-30 | Nitinol Medical Technologies, Inc. | Stent and method and apparatus for forming and delivering the same |
DE4215449C1 (en) | 1992-05-11 | 1993-09-02 | Ethicon Gmbh & Co Kg, 2000 Norderstedt, De | |
US5336252A (en) | 1992-06-22 | 1994-08-09 | Cohen Donald M | System and method for implanting cardiac electrical leads |
US5312341A (en) | 1992-08-14 | 1994-05-17 | Wayne State University | Retaining apparatus and procedure for transseptal catheterization |
US5304184A (en) | 1992-10-19 | 1994-04-19 | Indiana University Foundation | Apparatus and method for positive closure of an internal tissue membrane opening |
US5304185A (en) | 1992-11-04 | 1994-04-19 | Unisurge, Inc. | Needle holder |
US5357979A (en) | 1992-12-01 | 1994-10-25 | Intelliwire, Inc. | Flexible elongate device having a distal extremity with current controlled adjustable stiffness and adjustable bend location and method |
US5320633A (en) * | 1992-12-10 | 1994-06-14 | William C. Allen | Method and system for repairing a tear in the meniscus |
US5417699A (en) | 1992-12-10 | 1995-05-23 | Perclose Incorporated | Device and method for the percutaneous suturing of a vascular puncture site |
US5284488A (en) | 1992-12-23 | 1994-02-08 | Sideris Eleftherios B | Adjustable devices for the occlusion of cardiac defects |
US6346074B1 (en) | 1993-02-22 | 2002-02-12 | Heartport, Inc. | Devices for less invasive intracardiac interventions |
US5797960A (en) | 1993-02-22 | 1998-08-25 | Stevens; John H. | Method and apparatus for thoracoscopic intracardiac procedures |
US5312435A (en) | 1993-05-17 | 1994-05-17 | Kensey Nash Corporation | Fail predictable, reinforced anchor for hemostatic puncture closure |
US6001085A (en) | 1993-08-13 | 1999-12-14 | Daig Corporation | Coronary sinus catheter |
JP3185906B2 (en) | 1993-11-26 | 2001-07-11 | ニプロ株式会社 | Prosthesis for atrial septal defect |
US5545138A (en) | 1994-02-28 | 1996-08-13 | Medtronic, Inc. | Adjustable stiffness dilatation catheter |
JPH07265329A (en) | 1994-03-31 | 1995-10-17 | Fuji Photo Optical Co Ltd | Puncture high frequency treatment device |
US5683411A (en) | 1994-04-06 | 1997-11-04 | William Cook Europe A/S | Medical article for implantation into the vascular system of a patient |
US5601571A (en) | 1994-05-17 | 1997-02-11 | Moss; Gerald | Surgical fastener implantation device |
US5470337A (en) * | 1994-05-17 | 1995-11-28 | Moss; Gerald | Surgical fastener |
USRE38335E1 (en) | 1994-05-24 | 2003-11-25 | Endius Incorporated | Surgical instrument |
US5725552A (en) | 1994-07-08 | 1998-03-10 | Aga Medical Corporation | Percutaneous catheter directed intravascular occlusion devices |
US5433727A (en) | 1994-08-16 | 1995-07-18 | Sideris; Eleftherios B. | Centering buttoned device for the occlusion of large defects for occluding |
US5573542A (en) | 1994-08-17 | 1996-11-12 | Tahoe Surgical Instruments-Puerto Rico | Endoscopic suture placement tool |
US5577299A (en) | 1994-08-26 | 1996-11-26 | Thompson; Carl W. | Quick-release mechanical knot apparatus |
US5601575A (en) | 1994-09-02 | 1997-02-11 | Ethicon Endo-Surgery, Inc. | Needle driving device |
US5618311A (en) | 1994-09-28 | 1997-04-08 | Gryskiewicz; Joseph M. | Surgical subcuticular fastener system |
DE4440346A1 (en) | 1994-11-13 | 1996-05-15 | Daum Gmbh | Puncture instrument |
US5879366A (en) | 1996-12-20 | 1999-03-09 | W.L. Gore & Associates, Inc. | Self-expanding defect closure device and method of making and using |
US6171329B1 (en) | 1994-12-19 | 2001-01-09 | Gore Enterprise Holdings, Inc. | Self-expanding defect closure device and method of making and using |
US5713908A (en) | 1995-01-09 | 1998-02-03 | Jameel; Irfan Mufty | Laparascopic suturing instrument |
US5702421A (en) | 1995-01-11 | 1997-12-30 | Schneidt; Bernhard | Closure device for closing a vascular opening, such as patent ductus arteriosus |
US5634936A (en) | 1995-02-06 | 1997-06-03 | Scimed Life Systems, Inc. | Device for closing a septal defect |
US5649959A (en) | 1995-02-10 | 1997-07-22 | Sherwood Medical Company | Assembly for sealing a puncture in a vessel |
US5733337A (en) | 1995-04-07 | 1998-03-31 | Organogenesis, Inc. | Tissue repair fabric |
US6322548B1 (en) | 1995-05-10 | 2001-11-27 | Eclipse Surgical Technologies | Delivery catheter system for heart chamber |
US6132438A (en) | 1995-06-07 | 2000-10-17 | Ep Technologies, Inc. | Devices for installing stasis reducing means in body tissue |
US5827216A (en) | 1995-06-07 | 1998-10-27 | Cormedics Corp. | Method and apparatus for accessing the pericardial space |
US6562052B2 (en) | 1995-08-24 | 2003-05-13 | Sutura, Inc. | Suturing device and method |
US5836311A (en) | 1995-09-20 | 1998-11-17 | Medtronic, Inc. | Method and apparatus for temporarily immobilizing a local area of tissue |
DE69612507T2 (en) | 1995-10-30 | 2001-08-09 | Childrens Medical Center | SELF-CENTERING, SHIELD-LIKE DEVICE FOR CLOSING A SEPTAL DEFECT |
US5868753A (en) | 1995-11-13 | 1999-02-09 | Schatz; Richard A. | Stent retrieval catheter |
US5618331A (en) * | 1995-12-04 | 1997-04-08 | Kemicraft Overseas Limited | Vapor phase fluidized bed sulfation of titaniferous materials |
DE19604817C2 (en) | 1996-02-09 | 2003-06-12 | Pfm Prod Fuer Die Med Ag | Device for closing defect openings in the human or animal body |
US5733294A (en) | 1996-02-28 | 1998-03-31 | B. Braun Medical, Inc. | Self expanding cardiovascular occlusion device, method of using and method of making the same |
US5853422A (en) | 1996-03-22 | 1998-12-29 | Scimed Life Systems, Inc. | Apparatus and method for closing a septal defect |
US6152918A (en) | 1996-04-05 | 2000-11-28 | Eclipse Surgical Technologies, Inc. | Laser device with auto-piercing tip for myocardial revascularization procedures |
AR001590A1 (en) | 1996-04-10 | 1997-11-26 | Jorge Alberto Baccaro | Abnormal vascular communications occluder device and applicator cartridge of said device |
AU3186897A (en) | 1996-05-08 | 1997-11-26 | Salviac Limited | An occluder device |
US6488706B1 (en) | 1996-05-08 | 2002-12-03 | Carag Ag | Device for plugging an opening such as in a wall of a hollow or tubular organ |
US5893856A (en) | 1996-06-12 | 1999-04-13 | Mitek Surgical Products, Inc. | Apparatus and method for binding a first layer of material to a second layer of material |
US5800516A (en) | 1996-08-08 | 1998-09-01 | Cordis Corporation | Deployable and retrievable shape memory stent/tube and method |
US5810848A (en) | 1996-08-21 | 1998-09-22 | Hayhurst; John O. | Suturing system |
WO1998007375A1 (en) | 1996-08-22 | 1998-02-26 | The Trustees Of Columbia University | Endovascular flexible stapling device |
US5741297A (en) | 1996-08-28 | 1998-04-21 | Simon; Morris | Daisy occluder and method for septal defect repair |
US5810884A (en) | 1996-09-09 | 1998-09-22 | Beth Israel Deaconess Medical Center | Apparatus and method for closing a vascular perforation after percutaneous puncture of a blood vessel in a living subject |
US6086610A (en) | 1996-10-22 | 2000-07-11 | Nitinol Devices & Components | Composite self expanding stent device having a restraining element |
US5861003A (en) | 1996-10-23 | 1999-01-19 | The Cleveland Clinic Foundation | Apparatus and method for occluding a defect or aperture within body surface |
US5976178A (en) * | 1996-11-07 | 1999-11-02 | Vascular Science Inc. | Medical grafting methods |
US5776162A (en) | 1997-01-03 | 1998-07-07 | Nitinol Medical Technologies, Inc. | Vessel implantable shape memory appliance with superelastic hinged joint |
JP3134287B2 (en) | 1997-01-30 | 2001-02-13 | 株式会社ニッショー | Catheter assembly for endocardial suture surgery |
JP3134288B2 (en) | 1997-01-30 | 2001-02-13 | 株式会社ニッショー | Endocardial suture surgery tool |
US5810867A (en) | 1997-04-28 | 1998-09-22 | Medtronic, Inc. | Dilatation catheter with varied stiffness |
US5997562A (en) | 1997-06-13 | 1999-12-07 | Percusurge, Inc. | Medical wire introducer and balloon protective sheath |
US5997556A (en) | 1997-06-30 | 1999-12-07 | Eva Corporation | Surgical fastener |
US6030007A (en) | 1997-07-07 | 2000-02-29 | Hughes Electronics Corporation | Continually adjustable nonreturn knot |
JPH11104071A (en) | 1997-08-05 | 1999-04-20 | Olympus Optical Co Ltd | Treating instrument for endoscope |
US6174322B1 (en) | 1997-08-08 | 2001-01-16 | Cardia, Inc. | Occlusion device for the closure of a physical anomaly such as a vascular aperture or an aperture in a septum |
US5964782A (en) | 1997-09-18 | 1999-10-12 | Scimed Life Systems, Inc. | Closure device and method |
US5902319A (en) | 1997-09-25 | 1999-05-11 | Daley; Robert J. | Bioabsorbable staples |
US6139563A (en) | 1997-09-25 | 2000-10-31 | Allegiance Corporation | Surgical device with malleable shaft |
US5895404A (en) | 1997-09-29 | 1999-04-20 | Ruiz; Carlos E. | Apparatus and methods for percutaneously forming a passageway between adjacent vessels or portions of a vessel |
US5989268A (en) | 1997-10-28 | 1999-11-23 | Boston Scientific Corporation | Endoscopic hemostatic clipping device |
US5976174A (en) | 1997-12-15 | 1999-11-02 | Ruiz; Carlos E. | Medical hole closure device and methods of use |
US6129755A (en) | 1998-01-09 | 2000-10-10 | Nitinol Development Corporation | Intravascular stent having an improved strut configuration |
US5944738A (en) | 1998-02-06 | 1999-08-31 | Aga Medical Corporation | Percutaneous catheter directed constricting occlusion device |
JP3799810B2 (en) | 1998-03-30 | 2006-07-19 | ニプロ株式会社 | Transcatheter surgery closure plug and catheter assembly |
US6241740B1 (en) | 1998-04-09 | 2001-06-05 | Origin Medsystems, Inc. | System and method of use for ligating and cutting tissue |
US5993475A (en) | 1998-04-22 | 1999-11-30 | Bristol-Myers Squibb Co. | Tissue repair device |
US6332877B1 (en) | 1998-05-12 | 2001-12-25 | Novartis Ag | Ostomy tube placement tip |
US6113609A (en) | 1998-05-26 | 2000-09-05 | Scimed Life Systems, Inc. | Implantable tissue fastener and system for treating gastroesophageal reflux disease |
US6607541B1 (en) | 1998-06-03 | 2003-08-19 | Coalescent Surgical, Inc. | Tissue connector apparatus and methods |
US6740101B2 (en) | 1998-06-10 | 2004-05-25 | Converge Medical, Inc. | Sutureless anastomosis systems |
US6328822B1 (en) | 1998-06-26 | 2001-12-11 | Kiyohito Ishida | Functionally graded alloy, use thereof and method for producing same |
US6302903B1 (en) | 1998-07-07 | 2001-10-16 | Medtronic, Inc. | Straight needle apparatus for creating a virtual electrode used for the ablation of tissue |
US6165183A (en) | 1998-07-15 | 2000-12-26 | St. Jude Medical, Inc. | Mitral and tricuspid valve repair |
EP1105181B1 (en) | 1998-08-19 | 2004-02-04 | Cook Incorporated | Preformed wire guide |
US6149664A (en) | 1998-08-27 | 2000-11-21 | Micrus Corporation | Shape memory pusher introducer for vasoocclusive devices |
AU758587B2 (en) | 1998-09-15 | 2003-03-27 | Medtronic, Inc. | Method and apparatus for temporarily immobilizing a local area of tissue |
US6007558A (en) | 1998-09-25 | 1999-12-28 | Nitinol Medical Technologies, Inc. | Removable embolus blood clot filter |
US5919200A (en) | 1998-10-09 | 1999-07-06 | Hearten Medical, Inc. | Balloon catheter for abrading a patent foramen ovale and method of using the balloon catheter |
US6245062B1 (en) | 1998-10-23 | 2001-06-12 | Afx, Inc. | Directional reflector shield assembly for a microwave ablation instrument |
US6162202A (en) | 1998-10-26 | 2000-12-19 | Sicurelli; Robert | Flexible syringe needle |
US6482210B1 (en) | 1998-11-12 | 2002-11-19 | Orthopaedic Biosystems, Ltd., Inc. | Soft tissue/ligament to bone fixation device with inserter |
JP3906475B2 (en) | 1998-12-22 | 2007-04-18 | ニプロ株式会社 | Transcatheter surgery closure plug and catheter assembly |
US6142975A (en) | 1998-12-31 | 2000-11-07 | Advanced Cardiovascular Systems, Inc. | Guidewire having braided wire over drawn tube construction |
US6228097B1 (en) | 1999-01-22 | 2001-05-08 | Scion International, Inc. | Surgical instrument for clipping and cutting blood vessels and organic structures |
US6217590B1 (en) | 1999-01-22 | 2001-04-17 | Scion International, Inc. | Surgical instrument for applying multiple staples and cutting blood vessels and organic structures and method therefor |
US6206921B1 (en) | 1999-02-22 | 2001-03-27 | Peter A. Guagliano | Method of replacing nucleus pulposus and repairing the intervertebral disk |
US6352531B1 (en) | 1999-03-24 | 2002-03-05 | Micrus Corporation | Variable stiffness optical fiber shaft |
ATE305324T1 (en) | 1999-03-29 | 2005-10-15 | William Cook Europe As | A GUIDE WIRE |
US6277139B1 (en) | 1999-04-01 | 2001-08-21 | Scion Cardio-Vascular, Inc. | Vascular protection and embolic material retriever |
US6277138B1 (en) | 1999-08-17 | 2001-08-21 | Scion Cardio-Vascular, Inc. | Filter for embolic material mounted on expandable frame |
US6379342B1 (en) | 1999-04-02 | 2002-04-30 | Scion International, Inc. | Ampoule for dispensing medication and method of use |
JP2000300571A (en) | 1999-04-19 | 2000-10-31 | Nissho Corp | Closure plug for transcatheter operation |
AU4670600A (en) | 1999-04-30 | 2000-11-17 | Paper-Pak Products, Inc. | Absorbent pads having theft alarm activators therein |
US6206907B1 (en) | 1999-05-07 | 2001-03-27 | Cardia, Inc. | Occlusion device with stranded wire support arms |
US6712836B1 (en) | 1999-05-13 | 2004-03-30 | St. Jude Medical Atg, Inc. | Apparatus and methods for closing septal defects and occluding blood flow |
US6379368B1 (en) | 1999-05-13 | 2002-04-30 | Cardia, Inc. | Occlusion device with non-thrombogenic properties |
US6375635B1 (en) | 1999-05-18 | 2002-04-23 | Hydrocision, Inc. | Fluid jet surgical instruments |
US6325807B1 (en) | 1999-06-11 | 2001-12-04 | Scimed Life Systems, Inc. | Variable strength sheath |
US6165204A (en) | 1999-06-11 | 2000-12-26 | Scion International, Inc. | Shaped suture clip, appliance and method therefor |
US6494888B1 (en) | 1999-06-22 | 2002-12-17 | Ndo Surgical, Inc. | Tissue reconfiguration |
US6206895B1 (en) | 1999-07-13 | 2001-03-27 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US6245080B1 (en) | 1999-07-13 | 2001-06-12 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US6398796B2 (en) | 1999-07-13 | 2002-06-04 | Scion Cardio-Vascular, Inc. | Suture with toggle and delivery system |
US7892246B2 (en) | 1999-07-28 | 2011-02-22 | Bioconnect Systems, Inc. | Devices and methods for interconnecting conduits and closing openings in tissue |
US6685724B1 (en) | 1999-08-24 | 2004-02-03 | The Penn State Research Foundation | Laparoscopic surgical instrument and method |
DE20101699U1 (en) | 2001-01-31 | 2001-05-03 | Gip Medizintechnik Gmbh | Device for eliminating or at least reducing gaps between three elements arranged one behind the other in the longitudinal direction |
US6231561B1 (en) | 1999-09-20 | 2001-05-15 | Appriva Medical, Inc. | Method and apparatus for closing a body lumen |
US6387104B1 (en) | 1999-11-12 | 2002-05-14 | Scimed Life Systems, Inc. | Method and apparatus for endoscopic repair of the lower esophageal sphincter |
US6371971B1 (en) | 1999-11-15 | 2002-04-16 | Scimed Life Systems, Inc. | Guidewire filter and methods of use |
US7335426B2 (en) | 1999-11-19 | 2008-02-26 | Advanced Bio Prosthetic Surfaces, Ltd. | High strength vacuum deposited nitinol alloy films and method of making same |
US6790218B2 (en) | 1999-12-23 | 2004-09-14 | Swaminathan Jayaraman | Occlusive coil manufacture and delivery |
US6780197B2 (en) | 2000-01-05 | 2004-08-24 | Integrated Vascular Systems, Inc. | Apparatus and methods for delivering a vascular closure device to a body lumen |
CA2398967A1 (en) | 2000-02-01 | 2001-08-09 | Albert C. Lardo | Magnetic resonance imaging transseptal needle antenna |
US6537198B1 (en) | 2000-03-21 | 2003-03-25 | Myocor, Inc. | Splint assembly for improving cardiac function in hearts, and method for implanting the splint assembly |
US6650923B1 (en) | 2000-04-13 | 2003-11-18 | Ev3 Sunnyvale, Inc. | Method for accessing the left atrium of the heart by locating the fossa ovalis |
US7056294B2 (en) | 2000-04-13 | 2006-06-06 | Ev3 Sunnyvale, Inc | Method and apparatus for accessing the left atrial appendage |
JP3844661B2 (en) | 2000-04-19 | 2006-11-15 | ラディ・メディカル・システムズ・アクチェボラーグ | Intra-arterial embolus |
US6551344B2 (en) | 2000-04-26 | 2003-04-22 | Ev3 Inc. | Septal defect occluder |
US6214029B1 (en) | 2000-04-26 | 2001-04-10 | Microvena Corporation | Septal defect occluder |
US6352552B1 (en) | 2000-05-02 | 2002-03-05 | Scion Cardio-Vascular, Inc. | Stent |
US6334864B1 (en) | 2000-05-17 | 2002-01-01 | Aga Medical Corp. | Alignment member for delivering a non-symmetric device with a predefined orientation |
US6440152B1 (en) | 2000-07-28 | 2002-08-27 | Microvena Corporation | Defect occluder release assembly and method |
EP1320329A4 (en) | 2000-09-01 | 2004-09-22 | Advanced Vasular Technologies | Endovascular fastener and grafting apparatus and method |
US6364853B1 (en) | 2000-09-11 | 2002-04-02 | Scion International, Inc. | Irrigation and suction valve and method therefor |
JP2004508884A (en) | 2000-09-25 | 2004-03-25 | コヒージョン テクノロジーズ, インコーポレイテッド | Resorbable anastomotic stent and plug |
US6375625B1 (en) | 2000-10-18 | 2002-04-23 | Scion Valley, Inc. | In-line specimen trap and method therefor |
FR2817142B1 (en) * | 2000-11-24 | 2003-05-16 | Sofradim Production | PROSTHETIC FASTENER AND TRANSCUTANEOUS INSERTION DEVICE |
US6746404B2 (en) | 2000-12-18 | 2004-06-08 | Biosense, Inc. | Method for anchoring a medical device between tissue |
US20020128680A1 (en) | 2001-01-25 | 2002-09-12 | Pavlovic Jennifer L. | Distal protection device with electrospun polymer fiber matrix |
US6550480B2 (en) | 2001-01-31 | 2003-04-22 | Numed/Tech Llc | Lumen occluders made from thermodynamic materials |
US20020107531A1 (en) | 2001-02-06 | 2002-08-08 | Schreck Stefan G. | Method and system for tissue repair using dual catheters |
US6692471B2 (en) | 2001-02-16 | 2004-02-17 | Medex, Inc. | Method and apparatus for safety catheter insertion device |
US6623518B2 (en) | 2001-02-26 | 2003-09-23 | Ev3 Peripheral, Inc. | Implant delivery system with interlock |
US7037305B2 (en) | 2001-04-30 | 2006-05-02 | Ethicon, Inc. | Heart presentation device and method |
US6544274B2 (en) | 2001-05-02 | 2003-04-08 | Novare Surgical Systems, Inc. | Clamp having bendable shaft |
US6537300B2 (en) | 2001-05-30 | 2003-03-25 | Scimed Life Systems, Inc. | Implantable obstruction device for septal defects |
US7338514B2 (en) | 2001-06-01 | 2008-03-04 | St. Jude Medical, Cardiology Division, Inc. | Closure devices, related delivery methods and tools, and related methods of use |
US7288105B2 (en) | 2001-08-01 | 2007-10-30 | Ev3 Endovascular, Inc. | Tissue opening occluder |
US6663592B2 (en) | 2001-09-06 | 2003-12-16 | Medex, Inc. | Catheter introducer assembly having safety shielded needle |
US6776784B2 (en) | 2001-09-06 | 2004-08-17 | Core Medical, Inc. | Clip apparatus for closing septal defects and methods of use |
US6702835B2 (en) | 2001-09-07 | 2004-03-09 | Core Medical, Inc. | Needle apparatus for closing septal defects and methods for using such apparatus |
US6596013B2 (en) | 2001-09-20 | 2003-07-22 | Scimed Life Systems, Inc. | Method and apparatus for treating septal defects |
US6652486B2 (en) | 2001-09-27 | 2003-11-25 | Medex, Inc. | Safety catheter |
US6730062B2 (en) | 2001-10-11 | 2004-05-04 | Medex, Inc. | Safety catheter with non-removable retractable needle |
US7220265B2 (en) | 2002-01-14 | 2007-05-22 | Nmt Medical, Inc. | Patent foramen ovale (PFO) closure method and device |
US20030139819A1 (en) | 2002-01-18 | 2003-07-24 | Beer Nicholas De | Method and apparatus for closing septal defects |
SE0200193L (en) | 2002-01-22 | 2003-09-17 | Jomed Nv | An endoscopic kit |
US7588585B2 (en) | 2002-03-26 | 2009-09-15 | Novare Surgical Systems, Inc. | Handleless clamping device |
US7976564B2 (en) | 2002-05-06 | 2011-07-12 | St. Jude Medical, Cardiology Division, Inc. | PFO closure devices and related methods of use |
US6855124B1 (en) | 2002-10-02 | 2005-02-15 | Advanced Cardiovascular Systems, Inc. | Flexible polymer needle catheter |
US8021359B2 (en) | 2003-02-13 | 2011-09-20 | Coaptus Medical Corporation | Transseptal closure of a patent foramen ovale and other cardiac defects |
US7186251B2 (en) | 2003-03-27 | 2007-03-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
US6939348B2 (en) | 2003-03-27 | 2005-09-06 | Cierra, Inc. | Energy based devices and methods for treatment of patent foramen ovale |
US7165552B2 (en) | 2003-03-27 | 2007-01-23 | Cierra, Inc. | Methods and apparatus for treatment of patent foramen ovale |
WO2004087235A2 (en) | 2003-03-27 | 2004-10-14 | Cierra, Inc. | Methods and apparatus for treatment of patent foramen ovale |
US7293562B2 (en) | 2003-03-27 | 2007-11-13 | Cierra, Inc. | Energy based devices and methods for treatment of anatomic tissue defects |
US7666203B2 (en) | 2003-11-06 | 2010-02-23 | Nmt Medical, Inc. | Transseptal puncture apparatus |
US7367975B2 (en) | 2004-06-21 | 2008-05-06 | Cierra, Inc. | Energy based devices and methods for treatment of anatomic tissue defects |
-
2004
- 2004-04-27 US US10/833,725 patent/US7691112B2/en active Active
- 2004-04-27 WO PCT/US2004/012913 patent/WO2005034763A1/en active Application Filing
- 2004-04-27 CA CA002538476A patent/CA2538476A1/en not_active Abandoned
- 2004-04-27 JP JP2006526055A patent/JP2007504885A/en active Pending
- 2004-04-27 EP EP04750710A patent/EP1663011A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1663011A1 (en) | 2006-06-07 |
WO2005034763A8 (en) | 2008-05-08 |
JP2007504885A (en) | 2007-03-08 |
US20050059984A1 (en) | 2005-03-17 |
US7691112B2 (en) | 2010-04-06 |
WO2005034763A1 (en) | 2005-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7691112B2 (en) | Devices, systems, and methods for suturing tissue | |
US7066944B2 (en) | Surgical fastening system | |
EP1857052B1 (en) | Devices for closing a patent foramen ovale | |
EP1933720B1 (en) | Vascular opening edge eversion apparatuses | |
US20070083232A1 (en) | Vascular closure device | |
EP1236437B1 (en) | Vascular puncture site suturing device | |
EP1682007B1 (en) | Patent foramen ovale closure system | |
EP2197355B1 (en) | Closure medical device | |
US20070083231A1 (en) | Vascular closure | |
US20100234854A1 (en) | Systems and Methods for Treating Septal Defects with Capture Devices and Other Devices | |
US20070073337A1 (en) | Clip-Based Systems And Methods For Treating Septal Defects | |
AU2008321050A1 (en) | Fistula grafts and related methods and systems useful for treating gastrointestinal and other fistulae | |
AU2008247622A1 (en) | Systems and methods for accommodating anatomical characteristics in the treatment of septal defects | |
EP3634258A1 (en) | Closing device for tissue openings | |
US9877711B2 (en) | Expandable vascular closure plug | |
EP1876964A2 (en) | System and method for bonding closure of an intra-cardiac opening using energy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |